<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="protocol"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id><journal-id journal-id-type="hwp">bmjopen</journal-id><journal-id journal-id-type="publisher-id">bmjopen</journal-id><journal-title-group><journal-title>BMJ Open</journal-title></journal-title-group><issn pub-type="epub">2044-6055</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27633643</article-id><article-id pub-id-type="pmc">5030556</article-id><article-id pub-id-type="publisher-id">bmjopen-2016-012743</article-id><article-id pub-id-type="doi">10.1136/bmjopen-2016-012743</article-id><article-categories><subj-group subj-group-type="heading"><subject>Mental Health</subject><subj-group><subject>Protocol</subject></subj-group></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1712</subject><subject>1719</subject></subj-group></article-categories><title-group><article-title>Comparing group-based acceptance and commitment therapy (ACT) with enhanced usual care for adolescents with functional somatic syndromes: a study protocol for a randomised trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kallesøe</surname><given-names>Karen Hansen</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schröder</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wicksell</surname><given-names>Rikard K</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Fink</surname><given-names>Per</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ørnbøl</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rask</surname><given-names>Charlotte Ulrikka</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af3">3</xref></contrib></contrib-group><aff id="af1"><label>1</label><institution>Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital</institution>, <addr-line>Aarhus</addr-line>, <country>Denmark</country></aff><aff id="af2"><label>2</label><institution>Behavior Medicine Pain Treatment Services, Karolinska</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff><aff id="af3"><label>3</label><institution>Regional Centre for Child and Adolescent Psychiatry, Risskov, Aarhus University Hospital</institution>, <addr-line>Aarhus</addr-line>, <country>Denmark</country></aff><author-notes><corresp><label>Correspondence to</label> Dr Karen Hansen Kallesøe; <email>karkal@rm.dk</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>15</day><month>9</month><year>2016</year></pub-date><volume>6</volume><issue>9</issue><elocation-id>e012743</elocation-id><history><date date-type="received"><day>20</day><month>5</month><year>2016</year></date><date date-type="rev-recd"><day>17</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjopen-2016-012743.pdf"></self-uri><abstract><sec><title><offsets xml_i="4631" xml_f="4643" txt_i="11" txt_f="23">Introduction</offsets></title><p><offsets xml_i="4654" xml_f="5204" txt_i="24" txt_f="574">Functional somatic syndromes (FSS) are common in adolescents, characterised by severe disability and reduced quality of life. Behavioural treatments such as acceptance and commitment therapy (ACT) has shown promising results in children and adolescents with FSS, but has focused on specific syndromes such as functional pain. The current study will compare the efficacy of group-based ACT with that of enhanced usual care (EUC) in adolescents with a range of FSS operationalised by the unifying construct of multiorgan bodily distress syndrome (BDS).</offsets></p></sec><sec><title><offsets xml_i="5226" xml_f="5246" txt_i="576" txt_f="596">Methods and analysis</offsets></title><p><offsets xml_i="5257" xml_f="6195" txt_i="597" txt_f="1535">A total of 120 adolescents aged 15–19 and diagnosed with multiorgan BDS, of at least 12 months duration, will be assessed and randomised to either: (1) EUC: a manualised consultation with a child and adolescent psychiatrist and individualised treatment plan or (2) manualised ACT-based group therapy plus EUC. The ACT programme consists of 9 modules (ie, 27 hours) and 1 follow-up meeting (3 hours). The primary outcome is physical health, assessed by an Short Form Health Survey (SF-36) aggregate score 12 months after randomisation. Secondary outcomes include self-reported symptom severity, symptom interference, depression and anxiety, illness worry, perceived stress and global improvement; as well as objective physical activity and bodily stress response measured by heart rate variability, hair cortisol and inflammatory biomarkers. Process measures are illness perception, illness-related behaviour and psychological flexibility.</offsets></p></sec><sec><title><offsets xml_i="6217" xml_f="6241" txt_i="1537" txt_f="1561">Ethics and dissemination</offsets></title><p><offsets xml_i="6252" xml_f="6546" txt_i="1562" txt_f="1856">The study is conducted in accordance with Helsinki Declaration II. Approval has been obtained from the Science Ethics Committee of the Central Denmark Region and the Danish Data Protection. The results will be sought to be published according to the CONSORT statement in peer-reviewed journals.</offsets></p></sec><sec><title><offsets xml_i="6568" xml_f="6578" txt_i="1858" txt_f="1868">Discussion</offsets></title><p><offsets xml_i="6589" xml_f="6743" txt_i="1869" txt_f="2023">This is one of the first larger randomised clinical trials evaluating the effect of a group-based intervention for adolescents with a range of severe FSS.</offsets></p></sec><sec><title><offsets xml_i="6765" xml_f="6790" txt_i="2025" txt_f="2050">Trial registration number</offsets></title><p><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02346071"><offsets xml_i="6892" xml_f="6903" txt_i="2051" txt_f="2062">NCT02346071</offsets></ext-link><offsets xml_i="6914" xml_f="6928" txt_i="2062" txt_f="2076">; Pre-results.</offsets></p></sec></abstract><kwd-group><kwd>Functional Somatic Syndromes</kwd><kwd>Adolescents</kwd><kwd>Randomised Controlled Trial</kwd><kwd>Study protocol</kwd><kwd>Psychotherapy</kwd><kwd>Medically Unexplained Symptoms</kwd></kwd-group></article-meta></front><body><boxed-text position="float" orientation="portrait"><caption><title><offsets xml_i="7258" xml_f="7298" txt_i="2085" txt_f="2125">Strengths and limitations of this study </offsets></title></caption><list list-type="bullet"><list-item><p><offsets xml_i="7355" xml_f="7407" txt_i="2126" txt_f="2178">Large-scale study in an area with limited knowledge.</offsets></p></list-item><list-item><p><offsets xml_i="7437" xml_f="7517" txt_i="2179" txt_f="2259">Evaluation of psychosocial and biological predictors and moderators of outcomes.</offsets></p></list-item><list-item><p><offsets xml_i="7547" xml_f="7649" txt_i="2260" txt_f="2362">Thorough assessment of all patients providing them with evidence-based understanding of their illness.</offsets></p></list-item><list-item><p><offsets xml_i="7679" xml_f="7779" txt_i="2363" txt_f="2463">Assessment and treatment are carried out in a specialised setting which might affect generalisation.</offsets></p></list-item><list-item><p><offsets xml_i="7809" xml_f="7983" txt_i="2464" txt_f="2638">Results not automatically applicable to younger adolescents given the developmental perspective, with multiple symptoms being less common in children and younger adolescents.</offsets></p></list-item></list></boxed-text><sec id="s1"><title><offsets xml_i="8039" xml_f="8049" txt_i="2639" txt_f="2649">Background</offsets></title><p><offsets xml_i="8060" xml_f="8475" txt_i="2650" txt_f="3065">Functional somatic syndromes (FSS), including chronic fatigue syndrome, juvenile fibromyalgia, functional gastrointestinal disorders and idiopathic pain syndromes, are well-known conditions in adolescents. FSS are diagnostic unities representing clusters of related functional somatic symptoms. Prevalence rates vary considerably due to differences in case definitions, assessment instruments and study populations.</offsets><xref rid="R1" ref-type="bibr"><offsets xml_i="8506" xml_f="8509" txt_i="3065" txt_f="3068">1–3</offsets></xref><offsets xml_i="8516" xml_f="8726" txt_i="3068" txt_f="3278"> Studies attempting to cover the whole range of different functional somatic symptoms suggest that 5–10% of children and adolescents in the general population are substantially affected and likely to need care.</offsets><xref rid="R4" ref-type="bibr"><offsets xml_i="8757" xml_f="8758" txt_i="3278" txt_f="3279">4</offsets></xref><offsets xml_i="8765" xml_f="8766" txt_i="3279" txt_f="3280">
</offsets><xref rid="R5" ref-type="bibr"><offsets xml_i="8797" xml_f="8798" txt_i="3280" txt_f="3281">5</offsets></xref><offsets xml_i="8805" xml_f="9030" txt_i="3281" txt_f="3506"> Suffering from FSS during adolescence often has high personal and societal consequences. Adolescents have a higher risk of psychosocial problems such as social isolation, long-term school absence and reduced quality of life,</offsets><xref rid="R6" ref-type="bibr"><offsets xml_i="9061" xml_f="9062" txt_i="3506" txt_f="3507">6</offsets></xref><offsets xml_i="9069" xml_f="9122" txt_i="3507" txt_f="3560"> and anxiety and depression are common comorbidities.</offsets><xref rid="R7" ref-type="bibr"><offsets xml_i="9153" xml_f="9154" txt_i="3560" txt_f="3561">7</offsets></xref><offsets xml_i="9161" xml_f="9162" txt_i="3561" txt_f="3562">
</offsets><xref rid="R8" ref-type="bibr"><offsets xml_i="9193" xml_f="9194" txt_i="3562" txt_f="3563">8</offsets></xref><offsets xml_i="9201" xml_f="9280" txt_i="3563" txt_f="3642"> A substantial proportion show continuity of functional symptoms into adulthood</offsets><xref rid="R9" ref-type="bibr"><offsets xml_i="9311" xml_f="9315" txt_i="3642" txt_f="3646">9–11</offsets></xref><offsets xml_i="9322" xml_f="9373" txt_i="3646" txt_f="3697"> and are less likely to obtain a college education.</offsets><xref rid="R9" ref-type="bibr"><offsets xml_i="9404" xml_f="9405" txt_i="3697" txt_f="3698">9</offsets></xref><offsets xml_i="9412" xml_f="9553" txt_i="3698" txt_f="3839"> Furthermore, adolescents diagnosed with FSS have higher overall healthcare costs due to increased use of medication and healthcare services.</offsets><xref rid="R9" ref-type="bibr"><offsets xml_i="9584" xml_f="9585" txt_i="3839" txt_f="3840">9</offsets></xref><offsets xml_i="9592" xml_f="9593" txt_i="3840" txt_f="3841">
</offsets><xref rid="R12" ref-type="bibr"><offsets xml_i="9625" xml_f="9627" txt_i="3841" txt_f="3843">12</offsets></xref><offsets xml_i="9634" xml_f="9808" txt_i="3843" txt_f="4017"> The aetiology of FSS remains unknown. Recent studies suggest a potential correlation between physiological stress and FSS, with physical inactivity as a potential covariate.</offsets><xref rid="R13" ref-type="bibr"><offsets xml_i="9840" xml_f="9845" txt_i="4017" txt_f="4022">13–16</offsets></xref><offsets xml_i="9852" xml_f="10029" txt_i="4022" txt_f="4199"> It is proposed that a (patho)physiological response to prolonged or severe mental and/or physical stress in genetically susceptible individuals may trigger symptom development.</offsets><xref rid="R17" ref-type="bibr"><offsets xml_i="10061" xml_f="10063" txt_i="4199" txt_f="4201">17</offsets></xref></p><p><offsets xml_i="10077" xml_f="10201" txt_i="4202" txt_f="4326">High co-occurrence of different types of FSS, especially various pain syndromes, has been shown in children and adolescents.</offsets><xref rid="R18" ref-type="bibr"><offsets xml_i="10233" xml_f="10238" txt_i="4326" txt_f="4331">18–20</offsets></xref><offsets xml_i="10245" xml_f="10425" txt_i="4331" txt_f="4511"> Children reporting multiple symptoms have an associated higher frequency of distress and impairment (eg, higher kindergarten/school absenteeism and consultations with physicians).</offsets><xref rid="R21" ref-type="bibr"><offsets xml_i="10457" xml_f="10459" txt_i="4511" txt_f="4513">21</offsets></xref><offsets xml_i="10466" xml_f="10613" txt_i="4513" txt_f="4660"> Moreover, adult patients presenting with multiple symptoms from several organ systems have a poorer prognosis and a higher risk of chronification.</offsets><xref rid="R22" ref-type="bibr"><offsets xml_i="10645" xml_f="10650" txt_i="4660" txt_f="4665">22–24</offsets></xref><offsets xml_i="10657" xml_f="10977" txt_i="4665" txt_f="4985"> Thus, an attempt to recognise the most severely affected patients with the highest illness burden may encompass sampling patients with the highest symptom load (ie, multiple symptoms from several organ systems). Recently, the empirically based unifying diagnostic category bodily distress syndrome (BDS) was introduced.</offsets><xref rid="R25" ref-type="bibr"><offsets xml_i="11009" xml_f="11011" txt_i="4985" txt_f="4987">25</offsets></xref><offsets xml_i="11018" xml_f="11299" txt_i="4987" txt_f="5268"> The diagnosis describes specific symptom patterns and includes a multiorgan subtype and four single organ subtypes; in adult samples, it has been shown to capture a range of FSS including fibromyalgia, irritable bowel syndrome, non-cardiac chest pain and chronic fatigue syndrome.</offsets><xref rid="R26" ref-type="bibr"><offsets xml_i="11331" xml_f="11333" txt_i="5268" txt_f="5270">26</offsets></xref><offsets xml_i="11340" xml_f="11518" txt_i="5270" txt_f="5448"> Multiorgan BDS comprising multiple symptoms from at least three specific symptom groups thus offers a diagnostic unity potentially including the most severely affected patients.</offsets></p><p><offsets xml_i="11525" xml_f="11639" txt_i="5449" txt_f="5563">Cognitive–behavioural therapy (CBT) has been shown to reduce symptoms and increase functioning in adults with FSS,</offsets><xref rid="R27" ref-type="bibr"><offsets xml_i="11671" xml_f="11676" txt_i="5563" txt_f="5568">27–30</offsets></xref><offsets xml_i="11683" xml_f="11847" txt_i="5568" txt_f="5732"> whereas the evidence for treatment in adolescents is sparse. Family-based CBT and internet-delivered CBT have proven effective in young patients with specific FSS.</offsets><xref rid="R31" ref-type="bibr"><offsets xml_i="11879" xml_f="11884" txt_i="5732" txt_f="5737">31–36</offsets></xref><offsets xml_i="11891" xml_f="12211" txt_i="5737" txt_f="6057"> However, the development of specifically tailored treatments for each FSS or symptom profile seems to be an inefficient strategy due to the costly nature of establishing separate clinics in each medical (sub)specialty, the fragmented care available and difficulty in handling multisymptomatic patients at those clinics.</offsets><xref rid="R17" ref-type="bibr"><offsets xml_i="12243" xml_f="12245" txt_i="6057" txt_f="6059">17</offsets></xref><offsets xml_i="12252" xml_f="12253" txt_i="6059" txt_f="6060">
</offsets><xref rid="R37" ref-type="bibr"><offsets xml_i="12285" xml_f="12287" txt_i="6060" txt_f="6062">37</offsets></xref><offsets xml_i="12294" xml_f="12295" txt_i="6062" txt_f="6063">
</offsets><xref rid="R38" ref-type="bibr"><offsets xml_i="12327" xml_f="12329" txt_i="6063" txt_f="6065">38</offsets></xref><offsets xml_i="12336" xml_f="12510" txt_i="6065" txt_f="6239"> Recent studies suggest that adult patients with various FSS can feasibly receive the same treatment delivered in a group format, regardless of their main functional symptom.</offsets><xref rid="R39" ref-type="bibr"><offsets xml_i="12542" xml_f="12544" txt_i="6239" txt_f="6241">39</offsets></xref><offsets xml_i="12551" xml_f="12552" txt_i="6241" txt_f="6242">
</offsets><xref rid="R40" ref-type="bibr"><offsets xml_i="12584" xml_f="12586" txt_i="6242" txt_f="6244">40</offsets></xref><offsets xml_i="12593" xml_f="12733" txt_i="6244" txt_f="6384"> In adolescents, group treatment has been widely used and shown to be feasible in the treatment of psychiatric and non-psychiatric diseases.</offsets><xref rid="R41" ref-type="bibr"><offsets xml_i="12765" xml_f="12767" txt_i="6384" txt_f="6386">41</offsets></xref><offsets xml_i="12774" xml_f="12775" txt_i="6386" txt_f="6387">
</offsets><xref rid="R42" ref-type="bibr"><offsets xml_i="12807" xml_f="12809" txt_i="6387" txt_f="6389">42</offsets></xref><offsets xml_i="12816" xml_f="12998" txt_i="6389" txt_f="6571"> Group format offers several benefits including peer modelling, diminishment of stigma, increased motivation and higher acceptance of feedback from peers as opposed to professionals.</offsets><xref rid="R43" ref-type="bibr"><offsets xml_i="13030" xml_f="13032" txt_i="6571" txt_f="6573">43</offsets></xref><offsets xml_i="13039" xml_f="13212" txt_i="6573" txt_f="6746"> Hence, a unified group-based treatment may be advantageous for adolescents with various FSS due to feasibility, accessibility of treatment and potential healthcare savings.</offsets></p><p><offsets xml_i="13219" xml_f="13369" txt_i="6747" txt_f="6897">Acceptance and commitment therapy (ACT), which derives from CBT, has shown promising results in children and adolescents with chronic functional pain.</offsets><xref rid="R44" ref-type="bibr"><offsets xml_i="13401" xml_f="13403" txt_i="6897" txt_f="6899">44</offsets></xref><offsets xml_i="13410" xml_f="13411" txt_i="6899" txt_f="6900">
</offsets><xref rid="R45" ref-type="bibr"><offsets xml_i="13443" xml_f="13445" txt_i="6900" txt_f="6902">45</offsets></xref><offsets xml_i="13452" xml_f="13626" txt_i="6902" txt_f="7076"> Evidence suggests that acceptance of pain is related to enhanced physical and emotional functioning, whereas attempts to control pain may lead to higher pain and disability.</offsets><xref rid="R46" ref-type="bibr"><offsets xml_i="13658" xml_f="13660" txt_i="7076" txt_f="7078">46</offsets></xref><offsets xml_i="13667" xml_f="13668" txt_i="7078" txt_f="7079">
</offsets><xref rid="R47" ref-type="bibr"><offsets xml_i="13700" xml_f="13702" txt_i="7079" txt_f="7081">47</offsets></xref><offsets xml_i="13709" xml_f="13882" txt_i="7081" txt_f="7254"> By reducing avoidance behaviour and symptom interference, ACT can increase functioning and enhance quality of life, through value-driven acceptance and exposure strategies.</offsets><xref rid="R48" ref-type="bibr"><offsets xml_i="13914" xml_f="13916" txt_i="7254" txt_f="7256">48</offsets></xref><offsets xml_i="13923" xml_f="14041" txt_i="7256" txt_f="7374"> Symptom avoidance seems to be a general problem leading to disability and lower quality of life in patients with FSS.</offsets><xref rid="R49" ref-type="bibr"><offsets xml_i="14073" xml_f="14075" txt_i="7374" txt_f="7376">49</offsets></xref><offsets xml_i="14082" xml_f="14215" txt_i="7376" txt_f="7509"> This provides a rationale for a therapeutic approach focused on reduction of avoidance behaviour and acceptance of somatic symptoms.</offsets></p><p><offsets xml_i="14222" xml_f="14402" txt_i="7510" txt_f="7690">The objective of the present trial is to examine the efficacy of ACT-based group therapy for adolescents with a range of FSS grouped under the unifying diagnosis of multiorgan BDS.</offsets><xref rid="R17" ref-type="bibr"><offsets xml_i="14434" xml_f="14436" txt_i="7690" txt_f="7692">17</offsets></xref><offsets xml_i="14443" xml_f="14784" txt_i="7692" txt_f="8033"> To do this, we will examine physical health and a range of other outcomes including level of functioning, symptom interference and emotional distress at baseline, at different time points throughout the trial, and also at 12-month follow-up. An add-on study includes measurement of physiological stress response and physical activity level.</offsets></p></sec><sec sec-type="methods" id="s2"><title><offsets xml_i="14833" xml_f="14840" txt_i="8035" txt_f="8042">Methods</offsets></title><sec id="s2a"><title><offsets xml_i="14869" xml_f="14875" txt_i="8043" txt_f="8049">Design</offsets></title><p><offsets xml_i="14886" xml_f="15060" txt_i="8050" txt_f="8224">Single-site, non-blinded randomised controlled trial (RCT) with two conditions: (1) group-based ACT and (2) enhanced usual care (EUC). Overall study design is illustrated in </offsets><xref ref-type="fig" rid="BMJOPEN2016012743F1"><offsets xml_i="15107" xml_f="15115" txt_i="8224" txt_f="8232">figure 1</offsets></xref><offsets xml_i="15122" xml_f="15123" txt_i="8232" txt_f="8233">.</offsets></p><fig id="BMJOPEN2016012743F1" orientation="portrait" position="float"><label><offsets xml_i="15204" xml_f="15212" txt_i="8234" txt_f="8242">Figure 1</offsets></label><caption><p><offsets xml_i="15232" xml_f="15422" txt_i="8242" txt_f="8432">Flow chart of participants with estimated numbers at each level. ACT, acceptance and commitment therapy; EUC, enhanced usual care; SCAN, Schedules for Clinical Assessment in Neuropsychiatry.</offsets></p></caption><graphic xlink:href="bmjopen2016012743f01"></graphic></fig></sec><sec id="s2b"><title><offsets xml_i="15522" xml_f="15529" txt_i="8434" txt_f="8441">Setting</offsets></title><p><offsets xml_i="15540" xml_f="15981" txt_i="8442" txt_f="8883">Patients will be enlisted from the Research Clinic for Functional Disorders and Psychosomatics, situated in a general medicine setting at Aarhus University Hospital, Denmark. The department is a specialist, tertiary service with extra resources allocated for assessment and treatment of patients with debilitating functional somatic symptoms. Enrolment starts in January 2015 and the data collection is expected to be finalised in June 2019.</offsets></p><p><offsets xml_i="15988" xml_f="16273" txt_i="8884" txt_f="9169">Prior to enrolment, an uncontrolled pilot study was performed to test the applicability of the multiorgan BDS diagnosis for this specific age group as well as the feasibility of the new group-based treatment programme. Twenty-one patients were included in the uncontrolled pilot study.</offsets></p></sec><sec id="s2c"><title><offsets xml_i="16304" xml_f="16315" txt_i="9171" txt_f="9182">Eligibility</offsets></title><p><offsets xml_i="16326" xml_f="16548" txt_i="9183" txt_f="9405">Eligibility criteria are multiorgan BDS, that is, at least three functional somatic symptoms from at least three symptom groups, moderate-to-severe impairment in daily life and symptom duration for a minimum of 12 months (</offsets><xref ref-type="table" rid="BMJOPEN2016012743TB1"><offsets xml_i="16598" xml_f="16605" txt_i="9405" txt_f="9412">table 1</offsets></xref><offsets xml_i="16612" xml_f="16614" txt_i="9412" txt_f="9414">).</offsets><xref rid="R22" ref-type="bibr"><offsets xml_i="16646" xml_f="16648" txt_i="9414" txt_f="9416">22</offsets></xref><offsets xml_i="16655" xml_f="16656" txt_i="9416" txt_f="9417">
</offsets><xref rid="R26" ref-type="bibr"><offsets xml_i="16688" xml_f="16690" txt_i="9417" txt_f="9419">26</offsets></xref></p><table-wrap id="BMJOPEN2016012743TB1" orientation="portrait" position="float"><label><offsets xml_i="16786" xml_f="16793" txt_i="9420" txt_f="9427">Table 1</offsets></label><caption><p><offsets xml_i="16813" xml_f="16878" txt_i="9427" txt_f="9492">Diagnostic criteria for multiorgan bodily distress syndrome (BDS)</offsets><xref rid="R25" ref-type="bibr"><offsets xml_i="16910" xml_f="16912" txt_i="9492" txt_f="9494">25</offsets></xref><offsets xml_i="16919" xml_f="16920" txt_i="9494" txt_f="9495">
</offsets><xref rid="R26" ref-type="bibr"><offsets xml_i="16952" xml_f="16954" txt_i="9495" txt_f="9497">26</offsets></xref></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"></col><col align="left" span="1"></col></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1"><offsets xml_i="17176" xml_f="17192" txt_i="9498" txt_f="9514">Gastrointestinal</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="17238" xml_f="17284" txt_i="9514" txt_f="9560">Cardiopulmonary (including autonomic symptoms)</offsets></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><offsets xml_i="17341" xml_f="17355" txt_i="9560" txt_f="9574">Abdominal pain</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17388" xml_f="17415" txt_i="9575" txt_f="9602">Palpitations/heart pounding</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="17457" xml_f="17463" txt_i="9603" txt_f="9609">Nausea</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17496" xml_f="17514" txt_i="9610" txt_f="9628">Hot or cold sweats</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="17556" xml_f="17586" txt_i="9629" txt_f="9659">Frequent loose bowel movements</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17619" xml_f="17650" txt_i="9660" txt_f="9691">Breathlessness without exertion</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="17692" xml_f="17701" txt_i="9692" txt_f="9701">Diarrhoea</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17734" xml_f="17750" txt_i="9702" txt_f="9718">Hyperventilation</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="17792" xml_f="17807" txt_i="9719" txt_f="9734">Feeling bloated</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17840" xml_f="17849" txt_i="9735" txt_f="9744">Dry mouth</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="17891" xml_f="17905" txt_i="9745" txt_f="9759">Regurgitations</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="17938" xml_f="17955" txt_i="9760" txt_f="9777">Trembling/shaking</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="17997" xml_f="18023" txt_i="9778" txt_f="9804">Burning sensation in chest</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18056" xml_f="18075" txt_i="9805" txt_f="9824">Churning in stomach</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18117" xml_f="18129" txt_i="9825" txt_f="9837">Constipation</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18162" xml_f="18182" txt_i="9838" txt_f="9858">Flushing or blushing</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18224" xml_f="18232" txt_i="9859" txt_f="9867">Vomiting</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18265" xml_f="18286" txt_i="9868" txt_f="9889">Precordial discomfort</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18328" xml_f="18343" txt_i="9890" txt_f="9905">Musculoskeletal</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18376" xml_f="18392" txt_i="9906" txt_f="9922">General symptoms</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18434" xml_f="18455" txt_i="9923" txt_f="9944">Muscular ache or pain</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18488" xml_f="18496" txt_i="9945" txt_f="9953">Headache</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18538" xml_f="18556" txt_i="9954" txt_f="9972">Pain in the joints</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18589" xml_f="18615" txt_i="9973" txt_f="9999">Concentration difficulties</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18657" xml_f="18697" txt_i="10000" txt_f="10040">Feeling of paresis or localised weakness</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18730" xml_f="18750" txt_i="10041" txt_f="10061">Impairment of memory</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18792" xml_f="18800" txt_i="10062" txt_f="10070">Backache</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18833" xml_f="18850" txt_i="10071" txt_f="10088">Excessive fatigue</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="18892" xml_f="18929" txt_i="10089" txt_f="10126">Pain moving from one place to another</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="18962" xml_f="18971" txt_i="10127" txt_f="10136">Dizziness</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="19013" xml_f="19055" txt_i="10137" txt_f="10179">Unpleasant numbness or tingling sensations</offsets></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="19130" xml_f="19150" txt_i="10181" txt_f="10201">Pain in arms or legs</offsets></td><td rowspan="1" colspan="1"></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="19233" xml_f="19398" txt_i="10203" txt_f="10368">Diagnostic criteria: Functional symptoms from at least three of the four symptom groups (see above), with at least three symptoms within each affected symptom group.</offsets></p></fn></table-wrap-foot></table-wrap></sec><sec id="s2d"><title><offsets xml_i="19465" xml_f="19497" txt_i="10370" txt_f="10402">Inclusion and exclusion criteria</offsets></title><p><offsets xml_i="19508" xml_f="19545" txt_i="10403" txt_f="10440">The study criteria are summarised in </offsets><xref ref-type="boxed-text" rid="bx1"><offsets xml_i="19583" xml_f="19588" txt_i="10440" txt_f="10445">box 1</offsets></xref><offsets xml_i="19595" xml_f="19597" txt_i="10445" txt_f="10447">.
</offsets><boxed-text id="bx1" position="float" orientation="portrait"><label><offsets xml_i="19665" xml_f="19670" txt_i="10447" txt_f="10452">Box 1</offsets></label><caption><title><offsets xml_i="19694" xml_f="19726" txt_i="10452" txt_f="10484">Inclusion and exclusion criteria</offsets></title></caption><p><offsets xml_i="19747" xml_f="19765" txt_i="10485" txt_f="10503">Inclusion criteria</offsets></p><p><offsets xml_i="19772" xml_f="19848" txt_i="10504" txt_f="10580">1. Bodily distress syndrome, multiorgan type of at least 12 months duration.</offsets></p><p><offsets xml_i="19855" xml_f="19886" txt_i="10581" txt_f="10612">2. 15–19-year-olds at referral.</offsets></p><p><offsets xml_i="19893" xml_f="19989" txt_i="10613" txt_f="10709">3. Raised since infancy in Denmark or born to Danish parents. Understand, speak and read Danish.</offsets></p><p><offsets xml_i="19996" xml_f="20029" txt_i="10710" txt_f="10743">4. Moderate or severe impairment.</offsets></p><p><offsets xml_i="20036" xml_f="20054" txt_i="10744" txt_f="10762">Exclusion criteria</offsets></p><p><offsets xml_i="20061" xml_f="20096" txt_i="10763" txt_f="10798">1. Not completing informed consent.</offsets></p><p><offsets xml_i="20103" xml_f="20190" txt_i="10799" txt_f="10886">2. Acute psychiatric disorder demanding other treatment, or if the patient is suicidal.</offsets></p><p><offsets xml_i="20197" xml_f="20488" txt_i="10887" txt_f="11178">3. A lifetime diagnosis of psychosis, mania or depression with psychotic symptoms (International Classification of Diseases, 10th Revision (ICD-10): F20–29, F30–31, F32.2, F33.3), serious cognitive deficits or developmental disorders such as mental retardation and autism (ICD-10: F70, F84).</offsets></p><p><offsets xml_i="20495" xml_f="20564" txt_i="11179" txt_f="11248">4. Substance abuse of, for example, narcotics, alcohol or medication.</offsets></p><p><offsets xml_i="20571" xml_f="20609" txt_i="11249" txt_f="11287">5. Pregnancy at the time of inclusion.</offsets></p><p><offsets xml_i="20616" xml_f="20784" txt_i="11288" txt_f="11456">6. Not suitable for group-based treatment, for example, patients with severe ADHD (ICD-10: F90), severe social phobia (ICD-10: F40.1) or conduct disorder (ICD-10: F91).</offsets></p></boxed-text></p></sec><sec id="s2e"><title><offsets xml_i="20832" xml_f="20854" txt_i="11459" txt_f="11481">Recruitment procedures</offsets></title><p><offsets xml_i="20865" xml_f="21178" txt_i="11482" txt_f="11795">A total of 120 adolescents (aged 15–19), referred from general practitioners (GP), practising medical specialists or hospital wards, will be recruited into the trial. All referrals are initially screened for eligibility by a team of physicians from the Research Clinic for Functional Disorders and Psychosomatics.</offsets></p></sec><sec id="s2f"><title><offsets xml_i="21209" xml_f="21219" txt_i="11797" txt_f="11807">Assessment</offsets></title><p><offsets xml_i="21230" xml_f="21631" txt_i="11808" txt_f="12209">Patients regarded as eligible undergo a standardised clinical psychiatric and somatic assessment, performed by a physician specialised or trained in child and adolescent psychiatry. The assessment consists of a: (1) review of former discharge letters, medical records and other relevant information, (2) standardised clinical interview, (3) Schedules for Clinical Assessment in Neuropsychiatry (SCAN),</offsets><xref rid="R50" ref-type="bibr"><offsets xml_i="21663" xml_f="21665" txt_i="12209" txt_f="12211">50</offsets></xref><offsets xml_i="21672" xml_f="22072" txt_i="12211" txt_f="12611"> which screens for general psychopathology and contains a detailed section on functional somatic symptoms, (4) screening for child and adolescent psychiatric disorders not covered by the SCAN, that is, attention deficit hyperactivity disorder (ADHD), autism and conduct disorder with specific sections from the child and adolescent psychiatric interview Development and Well-being Assessment (DAWBA),</offsets><xref rid="R51" ref-type="bibr"><offsets xml_i="22104" xml_f="22106" txt_i="12611" txt_f="12613">51</offsets></xref><offsets xml_i="22113" xml_f="22190" txt_i="12613" txt_f="12690"> (5) a clinicophysical/neurological examination and (6) standard blood tests.</offsets></p><p><offsets xml_i="22197" xml_f="22238" txt_i="12691" txt_f="12732">Patients meeting the study criteria (see </offsets><xref ref-type="boxed-text" rid="bx1"><offsets xml_i="22276" xml_f="22281" txt_i="12732" txt_f="12737">box 1</offsets></xref><offsets xml_i="22288" xml_f="22421" txt_i="12737" txt_f="12870">) are offered participation in the study and are subsequently asked to complete the consent form before enrolment and randomisation. </offsets><xref ref-type="fig" rid="BMJOPEN2016012743F1"><offsets xml_i="22468" xml_f="22476" txt_i="12870" txt_f="12878">Figure 1</offsets></xref><offsets xml_i="22483" xml_f="22531" txt_i="12878" txt_f="12926"> presents the flow of patients during the trial.</offsets></p></sec><sec id="s2g"><title><offsets xml_i="22562" xml_f="22585" txt_i="12928" txt_f="12951">Randomisation procedure</offsets></title><p><offsets xml_i="22596" xml_f="23208" txt_i="12952" txt_f="13564">Following baseline assessment, patients meeting all study criteria and consenting to participate are randomised to either EUC-based or group-based ACT. The randomisation is conducted by statisticians not involved in treatment. Permuted block randomisation with block sizes ranging from 14 to 16 made by means of a computer algorithm will be used to ensure balanced group sizes and allocation concealment. Patients consenting to participate receive an opaque envelope taken from a sequential order containing information on group allocation, ensuring that initial assessment is not influenced by group allocation.</offsets></p><p><offsets xml_i="23215" xml_f="23332" txt_i="13565" txt_f="13682">Since the study compares a psychological treatment with EUC, blinding of participants and therapists is not possible.</offsets></p></sec></sec><sec id="s3"><title><offsets xml_i="23368" xml_f="23381" txt_i="13685" txt_f="13698">Interventions</offsets></title><sec id="s3a"><title><offsets xml_i="23410" xml_f="23429" txt_i="13699" txt_f="13718">Enhanced usual care</offsets></title><p><offsets xml_i="23440" xml_f="24272" txt_i="13719" txt_f="14551">Patients allocated to EUC will have a psychiatric consultation of 1½ hours duration, ∼2 weeks after clinical assessment, with participation of the patient and his/her parents or close relatives. The consultation is manualised and includes psychoeducation related to the diagnosis of multiorgan BDS, health promoting strategies, advice on medication or other treatment, supplemented with written information on the BDS diagnosis and general recommendations. ACT elements are not incorporated or used in the consultation. The aim of the consultation is to increase the family's understanding of BDS and to optimise management in primary care and social services support by an individualised treatment plan sent to the patient's GP. The consultation is carried out by the child and adolescent psychiatrist doing the initial assessment.</offsets></p></sec><sec id="s3b"><title><offsets xml_i="24303" xml_f="24326" txt_i="14553" txt_f="14576">ACT-based group therapy</offsets></title><p><offsets xml_i="24337" xml_f="24777" txt_i="14577" txt_f="15017">Patients allocated to ACT-based group therapy receive the same psychiatric consultation as described above, before starting the manualised ACT treatment developed specifically for this patient group. The therapy is given in groups of 7–8 patients with nine modules (ie, 27 hours in total) over a period of 3 months and one follow-up meeting (3 hours) 3 months after module 9. Detailed information on the treatment programme is presented in </offsets><xref ref-type="fig" rid="BMJOPEN2016012743F2"><offsets xml_i="24824" xml_f="24832" txt_i="15017" txt_f="15025">figure 2</offsets></xref><offsets xml_i="24839" xml_f="25296" txt_i="15025" txt_f="15482">. The parents and other relevant close relatives (eg, siblings, boyfriends/girlfriends) are invited to participate in an information meeting, to support their resources to help the adolescent improve his/her functional level and ability to cope with the symptoms. One individual consultation with the adolescent and close relatives is offered shortly after module 8. After completed ACT therapy, an individualised treatment plan is sent to the patient's GP.</offsets></p><fig id="BMJOPEN2016012743F2" orientation="portrait" position="float"><label><offsets xml_i="25377" xml_f="25385" txt_i="15483" txt_f="15491">Figure 2</offsets></label><caption><p><offsets xml_i="25405" xml_f="26138" txt_i="15491" txt_f="16224">Overview of the group-based acceptance and commitment therapy treatment programme. The overall focus of the treatment is to increase the patients’ physical and emotional self-awareness, and to teach them skills to manage the distress associated with difficult thoughts, emotions and bodily sensations. Practical exercises throughout the treatment include experiential exercises focusing on identification of own values, barriers and avoidance behaviour, and mindfulness exercises focusing on allowance of the experience of here and now as it is and of being present. Gradual exposure is implemented through individually customised homework assignments in accordance with the identified personal values. BDS, bodily distress syndrome.</offsets></p></caption><graphic xlink:href="bmjopen2016012743f02"></graphic></fig><p><offsets xml_i="26214" xml_f="26332" txt_i="16225" txt_f="16343">Patients assigned to ACT therapy have to agree not to have any other psychological treatment for BDS while in therapy.</offsets></p></sec><sec id="s3c"><title><offsets xml_i="26363" xml_f="26415" txt_i="16345" txt_f="16397">Therapist training and adherence to treatment manual</offsets></title><p><offsets xml_i="26426" xml_f="26707" txt_i="16398" txt_f="16679">Therapists are child and adolescent psychiatrists and psychologists with specialist training in ACT. Clinicians well experienced in ACT and group therapy supervise the treatment. Sessions are videotaped and assessed by an external panel to ensure adherence to the treatment manual.</offsets></p></sec><sec id="s3d"><title><offsets xml_i="26738" xml_f="26762" txt_i="16681" txt_f="16705">Compliance and attrition</offsets></title><p><offsets xml_i="26773" xml_f="27061" txt_i="16706" txt_f="16994">Treatment compliance is assessed by recording the number of completed ACT modules. When applicable, participants are asked for their reasons for poor compliance or dropout. In the case of dropout from the ACT group therapy, data collection continues as planned with the patients’ consent.</offsets></p></sec></sec><sec id="s4"><title><offsets xml_i="27097" xml_f="27113" txt_i="16997" txt_f="17013">Outcome measures</offsets></title><p><offsets xml_i="27124" xml_f="27427" txt_i="17014" txt_f="17317">Outcome measures are obtained at six different time points: at baseline (ie, before assessment and randomisation) and at 2, 4, 6, 8 and 12 months after randomisation. These time points have been designed to follow the time schedule of the ACT group therapy to allow for evaluation of process variables. </offsets><xref ref-type="fig" rid="BMJOPEN2016012743F1"><offsets xml_i="27474" xml_f="27482" txt_i="17317" txt_f="17325">Figure 1</offsets></xref><offsets xml_i="27489" xml_f="27637" txt_i="17325" txt_f="17473"> depicts how these time points relate to assessment and treatment. Primary and secondary outcome measures are assessed by web-based questionnaires (</offsets><xref ref-type="table" rid="BMJOPEN2016012743TB2"><offsets xml_i="27687" xml_f="27694" txt_i="17473" txt_f="17480">table 2</offsets></xref><offsets xml_i="27701" xml_f="27884" txt_i="17480" txt_f="17663">). The questionnaies are distributed simultaneously to all patients within the randomised blocks regardless of treatment group. The primary end point is 12 months after randomisation.</offsets></p><table-wrap id="BMJOPEN2016012743TB2" orientation="portrait" position="float"><label><offsets xml_i="27973" xml_f="27980" txt_i="17664" txt_f="17671">Table 2</offsets></label><caption><p><offsets xml_i="28000" xml_f="28016" txt_i="17671" txt_f="17687">Outcome measures</offsets></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"></col><col align="left" span="1"></col><col align="left" span="1"></col><col align="left" span="1"></col><col align="left" span="1"></col><col align="left" span="1"></col><col align="left" span="1"></col><col align="left" span="1"></col></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1"><offsets xml_i="28429" xml_f="28430" txt_i="17688" txt_f="17689"> </offsets></th><th rowspan="1" colspan="1"></th><th align="left" colspan="6" rowspan="1"><offsets xml_i="28509" xml_f="28515" txt_i="17689" txt_f="17695">Months</offsets><hr></hr></th></tr><tr><th rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="28612" xml_f="28622" txt_i="17695" txt_f="17705">Instrument</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="28668" xml_f="28669" txt_i="17705" txt_f="17706">0</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="28715" xml_f="28716" txt_i="17706" txt_f="17707">2</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="28762" xml_f="28763" txt_i="17707" txt_f="17708">4</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="28809" xml_f="28810" txt_i="17708" txt_f="17709">6</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="28856" xml_f="28857" txt_i="17709" txt_f="17710">8</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="28903" xml_f="28905" txt_i="17710" txt_f="17712">12</offsets></th></tr></thead><tbody><tr><td colspan="8" rowspan="1"><bold><offsets xml_i="28968" xml_f="28999" txt_i="17712" txt_f="17743">Respondent: X=Patient; P=Parent</offsets></bold></td></tr><tr><td colspan="8" rowspan="1"><bold><offsets xml_i="29054" xml_f="29069" txt_i="17744" txt_f="17759">Primary outcome</offsets></bold></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="29118" xml_f="29134" txt_i="17760" txt_f="17776"> Physical health</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29167" xml_f="29172" txt_i="17777" txt_f="17782">SF-36</offsets><xref rid="R56" ref-type="bibr"><offsets xml_i="29204" xml_f="29206" txt_i="17782" txt_f="17784">56</offsets></xref><offsets xml_i="29213" xml_f="29214" txt_i="17784" txt_f="17785">
</offsets><xref rid="R57" ref-type="bibr"><offsets xml_i="29246" xml_f="29248" txt_i="17785" txt_f="17787">57</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="29288" xml_f="29289" txt_i="17788" txt_f="17789">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29322" xml_f="29323" txt_i="17790" txt_f="17791">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29356" xml_f="29357" txt_i="17792" txt_f="17793">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29390" xml_f="29391" txt_i="17794" txt_f="17795">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29424" xml_f="29425" txt_i="17796" txt_f="17797">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29458" xml_f="29459" txt_i="17798" txt_f="17799">X</offsets></td></tr><tr><td colspan="8" rowspan="1"><bold><offsets xml_i="29507" xml_f="29525" txt_i="17800" txt_f="17818">Secondary outcomes</offsets></bold></td></tr><tr><td rowspan="2" colspan="1"><offsets xml_i="29574" xml_f="29591" txt_i="17819" txt_f="17836"> Illness severity</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29624" xml_f="29631" txt_i="17837" txt_f="17844">SCL-som</offsets><xref rid="R58" ref-type="bibr"><offsets xml_i="29663" xml_f="29665" txt_i="17844" txt_f="17846">58</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="29705" xml_f="29706" txt_i="17847" txt_f="17848">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29739" xml_f="29740" txt_i="17849" txt_f="17850">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29773" xml_f="29774" txt_i="17851" txt_f="17852">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29807" xml_f="29808" txt_i="17853" txt_f="17854">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29841" xml_f="29842" txt_i="17855" txt_f="17856">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="29875" xml_f="29876" txt_i="17857" txt_f="17858">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="29918" xml_f="29931" txt_i="17859" txt_f="17872">BDS checklist</offsets><xref rid="R59" ref-type="bibr"><offsets xml_i="29963" xml_f="29965" txt_i="17872" txt_f="17874">59</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="30005" xml_f="30006" txt_i="17875" txt_f="17876">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="30171" xml_f="30172" txt_i="17881" txt_f="17882">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="30214" xml_f="30235" txt_i="17883" txt_f="17904"> Symptom interference</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30268" xml_f="30270" txt_i="17905" txt_f="17907">LI</offsets><xref rid="R52" ref-type="bibr"><offsets xml_i="30302" xml_f="30304" txt_i="17907" txt_f="17909">52</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="30344" xml_f="30346" txt_i="17910" txt_f="17912">XP</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="30445" xml_f="30447" txt_i="17915" txt_f="17917">XP</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30480" xml_f="30481" txt_i="17918" txt_f="17919">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30514" xml_f="30516" txt_i="17920" txt_f="17922">XP</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="30558" xml_f="30587" txt_i="17923" txt_f="17952"> Depression and anxiety score</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30620" xml_f="30629" txt_i="17953" txt_f="17962">SCL-8-6-4</offsets><xref rid="R58" ref-type="bibr"><offsets xml_i="30661" xml_f="30663" txt_i="17962" txt_f="17964">58</offsets></xref><offsets xml_i="30670" xml_f="30671" txt_i="17964" txt_f="17965">
</offsets><xref rid="R60" ref-type="bibr"><offsets xml_i="30703" xml_f="30708" txt_i="17965" txt_f="17970">60–62</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="30748" xml_f="30749" txt_i="17971" txt_f="17972">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="30848" xml_f="30849" txt_i="17975" txt_f="17976">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30882" xml_f="30883" txt_i="17977" txt_f="17978">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="30916" xml_f="30917" txt_i="17979" txt_f="17980">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="30959" xml_f="30973" txt_i="17981" txt_f="17995"> Mental health</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31006" xml_f="31011" txt_i="17996" txt_f="18001">SF-36</offsets><xref rid="R56" ref-type="bibr"><offsets xml_i="31043" xml_f="31045" txt_i="18001" txt_f="18003">56</offsets></xref><offsets xml_i="31052" xml_f="31053" txt_i="18003" txt_f="18004">
</offsets><xref rid="R57" ref-type="bibr"><offsets xml_i="31085" xml_f="31087" txt_i="18004" txt_f="18006">57</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="31127" xml_f="31128" txt_i="18007" txt_f="18008">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31161" xml_f="31162" txt_i="18009" txt_f="18010">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31195" xml_f="31196" txt_i="18011" txt_f="18012">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31229" xml_f="31230" txt_i="18013" txt_f="18014">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31263" xml_f="31264" txt_i="18015" txt_f="18016">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31297" xml_f="31298" txt_i="18017" txt_f="18018">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="31340" xml_f="31354" txt_i="18019" txt_f="18033"> Illness worry</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31387" xml_f="31397" txt_i="18034" txt_f="18044">Whiteley-7</offsets><xref rid="R63" ref-type="bibr"><offsets xml_i="31429" xml_f="31431" txt_i="18044" txt_f="18046">63</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="31471" xml_f="31472" txt_i="18047" txt_f="18048">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31505" xml_f="31506" txt_i="18049" txt_f="18050">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31539" xml_f="31540" txt_i="18051" txt_f="18052">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31573" xml_f="31574" txt_i="18053" txt_f="18054">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31607" xml_f="31608" txt_i="18055" txt_f="18056">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31641" xml_f="31642" txt_i="18057" txt_f="18058">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="31684" xml_f="31701" txt_i="18059" txt_f="18076"> Perceived stress</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="31734" xml_f="31737" txt_i="18077" txt_f="18080">PSS</offsets><xref rid="R64" ref-type="bibr"><offsets xml_i="31769" xml_f="31771" txt_i="18080" txt_f="18082">64</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="31811" xml_f="31812" txt_i="18083" txt_f="18084">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="31977" xml_f="31978" txt_i="18089" txt_f="18090">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="32020" xml_f="32049" txt_i="18091" txt_f="18120"> Overall impression of change</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32082" xml_f="32086" txt_i="18121" txt_f="18125">PGIC</offsets><xref rid="R65" ref-type="bibr"><offsets xml_i="32118" xml_f="32120" txt_i="18125" txt_f="18127">65</offsets></xref></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="32259" xml_f="32261" txt_i="18131" txt_f="18133">XP</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32294" xml_f="32295" txt_i="18134" txt_f="18135">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32328" xml_f="32330" txt_i="18136" txt_f="18138">XP</offsets></td></tr><tr><td colspan="8" rowspan="1"><bold><offsets xml_i="32378" xml_f="32394" txt_i="18139" txt_f="18155">Process measures</offsets></bold></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="32443" xml_f="32462" txt_i="18156" txt_f="18175"> Illness perception</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32495" xml_f="32499" txt_i="18176" txt_f="18180">BIPQ</offsets><xref rid="R66" ref-type="bibr"><offsets xml_i="32531" xml_f="32533" txt_i="18180" txt_f="18182">66</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="32573" xml_f="32575" txt_i="18183" txt_f="18185">XP</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32608" xml_f="32609" txt_i="18186" txt_f="18187">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32642" xml_f="32643" txt_i="18188" txt_f="18189">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32676" xml_f="32678" txt_i="18190" txt_f="18192">XP</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32711" xml_f="32712" txt_i="18193" txt_f="18194">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32745" xml_f="32747" txt_i="18195" txt_f="18197">XP</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="32789" xml_f="32815" txt_i="18198" txt_f="18224"> Illness related behaviour</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32848" xml_f="32852" txt_i="18225" txt_f="18229">BRIQ</offsets><xref rid="R67" ref-type="bibr"><offsets xml_i="32884" xml_f="32886" txt_i="18229" txt_f="18231">67</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="32926" xml_f="32927" txt_i="18232" txt_f="18233">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32960" xml_f="32961" txt_i="18234" txt_f="18235">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="32994" xml_f="32995" txt_i="18236" txt_f="18237">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33028" xml_f="33029" txt_i="18238" txt_f="18239">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33062" xml_f="33063" txt_i="18240" txt_f="18241">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33096" xml_f="33097" txt_i="18242" txt_f="18243">X</offsets></td></tr><tr><td rowspan="2" colspan="1"><offsets xml_i="33139" xml_f="33165" txt_i="18244" txt_f="18270"> Psychological flexibility</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33198" xml_f="33204" txt_i="18271" txt_f="18277">AFQ-Y8</offsets><xref rid="R53" ref-type="bibr"><offsets xml_i="33236" xml_f="33238" txt_i="18277" txt_f="18279">53</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="33278" xml_f="33279" txt_i="18280" txt_f="18281">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33312" xml_f="33313" txt_i="18282" txt_f="18283">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33346" xml_f="33347" txt_i="18284" txt_f="18285">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33380" xml_f="33381" txt_i="18286" txt_f="18287">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33414" xml_f="33415" txt_i="18288" txt_f="18289">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33448" xml_f="33449" txt_i="18290" txt_f="18291">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="33491" xml_f="33498" txt_i="18292" txt_f="18299">PIPS-12</offsets><xref rid="R54" ref-type="bibr"><offsets xml_i="33530" xml_f="33532" txt_i="18299" txt_f="18301">54</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="33572" xml_f="33573" txt_i="18302" txt_f="18303">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33606" xml_f="33607" txt_i="18304" txt_f="18305">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33640" xml_f="33641" txt_i="18306" txt_f="18307">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33674" xml_f="33675" txt_i="18308" txt_f="18309">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33708" xml_f="33709" txt_i="18310" txt_f="18311">X</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33742" xml_f="33743" txt_i="18312" txt_f="18313">X</offsets></td></tr><tr><td colspan="8" rowspan="1"><bold><offsets xml_i="33791" xml_f="33811" txt_i="18314" txt_f="18334">Potential moderators</offsets></bold></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="33860" xml_f="33879" txt_i="18335" txt_f="18354"> Family functioning</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="33912" xml_f="33915" txt_i="18355" txt_f="18358">FAD</offsets><xref rid="R68" ref-type="bibr"><offsets xml_i="33947" xml_f="33949" txt_i="18358" txt_f="18360">68</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="33989" xml_f="33991" txt_i="18361" txt_f="18363">XP</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="34156" xml_f="34158" txt_i="18368" txt_f="18370">XP</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="34200" xml_f="34217" txt_i="18371" txt_f="18388"> Attachment style</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="34250" xml_f="34256" txt_i="18389" txt_f="18395">ECR-RS</offsets><xref rid="R69" ref-type="bibr"><offsets xml_i="34288" xml_f="34290" txt_i="18395" txt_f="18397">69</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="34330" xml_f="34331" txt_i="18398" txt_f="18399">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="34538" xml_f="34559" txt_i="18405" txt_f="18426"> Negative life events</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="34592" xml_f="34612" txt_i="18427" txt_f="18447">Negative life events</offsets><xref rid="R70" ref-type="bibr"><offsets xml_i="34644" xml_f="34646" txt_i="18447" txt_f="18449">70</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="34686" xml_f="34687" txt_i="18450" txt_f="18451">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td colspan="8" rowspan="1"><bold><offsets xml_i="34900" xml_f="34922" txt_i="18457" txt_f="18479">Physiological measures</offsets></bold></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="34971" xml_f="34975" txt_i="18480" txt_f="18484"> HRV</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="35008" xml_f="35094" txt_i="18485" txt_f="18571">HRV measured with the Vagus device (resting state, standing, slow breathing, valsalva)</offsets><xref rid="R71" ref-type="bibr"><offsets xml_i="35126" xml_f="35128" txt_i="18571" txt_f="18573">71</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="35168" xml_f="35169" txt_i="18574" txt_f="18575">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="35334" xml_f="35335" txt_i="18580" txt_f="18581">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="35377" xml_f="35391" txt_i="18582" txt_f="18596"> Hair cortisol</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="35424" xml_f="35503" txt_i="18597" txt_f="18676">Measurement of hair cortisol in 2 strands of hair closest to the scalp (1–2 cm)</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="35536" xml_f="35537" txt_i="18677" txt_f="18678">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="35702" xml_f="35703" txt_i="18683" txt_f="18684">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><offsets xml_i="35745" xml_f="35767" txt_i="18685" txt_f="18707"> Inflammatory response</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="35800" xml_f="35866" txt_i="18708" txt_f="18774">IL-6, TNF-α, high-sensitive CRP, IL-1, neopterin, CD163, HO1, MCP1</offsets></td><td rowspan="1" colspan="1"><offsets xml_i="35899" xml_f="35900" txt_i="18775" txt_f="18776">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="36065" xml_f="36066" txt_i="18781" txt_f="18782">X</offsets></td></tr><tr><td rowspan="1" colspan="1"><bold><offsets xml_i="36114" xml_f="36131" txt_i="18783" txt_f="18800">Physical activity</offsets></bold></td><td rowspan="1" colspan="1"><offsets xml_i="36171" xml_f="36233" txt_i="18801" txt_f="18863">Accelerometer (Actigraph wGT3X-BT) worn for 7 consecutive days</offsets><xref rid="R72" ref-type="bibr"><offsets xml_i="36265" xml_f="36267" txt_i="18863" txt_f="18865">72</offsets></xref></td><td rowspan="1" colspan="1"><offsets xml_i="36307" xml_f="36308" txt_i="18866" txt_f="18867">X</offsets></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"><offsets xml_i="36473" xml_f="36474" txt_i="18872" txt_f="18873">X</offsets></td></tr></tbody></table><table-wrap-foot><fn><p><offsets xml_i="36524" xml_f="37385" txt_i="18874" txt_f="19735">AFQ-Y8, Avoidance and Fusion Questionnaire for Youth; BDS, bodily distress syndrome; BIPQ, Brief Illness Perception Questionnaire; BRIQ, Behavioural Responses to Illness Questionnaire; CRP, C reactive protein; ECR-RS, Experience in Close Relationships—Relationship Structure; FAD, Family Assessment Device (general functioning subscale); HO1, heme oxygenase-1; HRV, heart rate variability; IL-6, interleukin 6; LI, Limitation Index (Revised from Pain Interference Index); MCP1, monocyte chemoattractant protein-1; P, parent; PGIC, Patient Global Impression of Change; PIPS-12, Psychological Inflexibility in Pain Scale; PSS, Perceived Stress Scale; SCL-8-6-4, Symptom Checklist Revised-90—depression and anxiety subscales; SCL-som, Symptom Checklist Revised-90—somatisation subscale; SF-36, Short Form Health Survey; TNF-α, tumour necrosis factor-α; X, patient.</offsets></p></fn></table-wrap-foot></table-wrap><p><offsets xml_i="37428" xml_f="37563" txt_i="19736" txt_f="19871">Owing to a study population of adolescents approaching adulthood (15+ years), questionnaires developed and tested in adults are chosen.</offsets></p><p><offsets xml_i="37570" xml_f="37614" txt_i="19872" txt_f="19916">Three questionnaires (Limitation Index (LI),</offsets><xref rid="R52" ref-type="bibr"><offsets xml_i="37646" xml_f="37648" txt_i="19916" txt_f="19918">52</offsets></xref><offsets xml_i="37655" xml_f="37709" txt_i="19918" txt_f="19972"> Avoidance and Fusion Questionnaire in Youth (AFQ-Y8),</offsets><xref rid="R53" ref-type="bibr"><offsets xml_i="37741" xml_f="37743" txt_i="19972" txt_f="19974">53</offsets></xref><offsets xml_i="37750" xml_f="37806" txt_i="19974" txt_f="20030"> and Psychological Inflexibility in Pain Scale (PIPS-12)</offsets><xref rid="R54" ref-type="bibr"><offsets xml_i="37838" xml_f="37840" txt_i="20030" txt_f="20032">54</offsets></xref><offsets xml_i="37847" xml_f="37981" txt_i="20032" txt_f="20166">) have been translated with reference to standard procedures with initial translation, synthesis of translations and back-translation.</offsets><xref rid="R55" ref-type="bibr"><offsets xml_i="38013" xml_f="38015" txt_i="20166" txt_f="20168">55</offsets></xref></p><sec id="s4a"><title><offsets xml_i="38047" xml_f="38062" txt_i="20169" txt_f="20184">Primary outcome</offsets></title><p><offsets xml_i="38073" xml_f="38302" txt_i="20185" txt_f="20414">The primary outcome is improvement in physical health 12 months after randomisation, measured with an aggregate score of the Short Form Health Survey (SF-36) subscales physical functioning (PF), bodily pain (BP) and vitality (VT)</offsets><xref rid="R56" ref-type="bibr"><offsets xml_i="38334" xml_f="38336" txt_i="20414" txt_f="20416">56</offsets></xref><offsets xml_i="38343" xml_f="38344" txt_i="20416" txt_f="20417">
</offsets><xref rid="R57" ref-type="bibr"><offsets xml_i="38376" xml_f="38378" txt_i="20417" txt_f="20419">57</offsets></xref><offsets xml_i="38385" xml_f="38510" txt_i="20419" txt_f="20544"> with a score range from 15 to 65. This score has previously been used as the primary outcome in a comparable trial in adults</offsets><xref rid="R39" ref-type="bibr"><offsets xml_i="38542" xml_f="38544" txt_i="20544" txt_f="20546">39</offsets></xref><offsets xml_i="38551" xml_f="38640" txt_i="20546" txt_f="20635"> due to well-known psychometric problems with the existing physical component score (PCS)</offsets><xref rid="R73" ref-type="bibr"><offsets xml_i="38672" xml_f="38674" txt_i="20635" txt_f="20637">73</offsets></xref><offsets xml_i="38681" xml_f="38796" txt_i="20637" txt_f="20752"> and based on the rationale that these three subscales have shown to be key domains affected in this patient group.</offsets><xref rid="R74" ref-type="bibr"><offsets xml_i="38828" xml_f="38830" txt_i="20752" txt_f="20754">74</offsets></xref><offsets xml_i="38837" xml_f="38885" txt_i="20754" txt_f="20802"> Danish norm data for adolescents are available.</offsets><xref rid="R56" ref-type="bibr"><offsets xml_i="38917" xml_f="38919" txt_i="20802" txt_f="20804">56</offsets></xref></p></sec><sec id="s4b"><title><offsets xml_i="38957" xml_f="38989" txt_i="20806" txt_f="20838">Self-reported secondary outcomes</offsets></title><p><offsets xml_i="39000" xml_f="39117" txt_i="20839" txt_f="20956">Illness severity is measured by two questionnaires. (1) The Somatisation subscale of the Symptom Checklist Revised-90</offsets><xref rid="R58" ref-type="bibr"><offsets xml_i="39149" xml_f="39151" txt_i="20956" txt_f="20958">58</offsets></xref><offsets xml_i="39158" xml_f="39159" txt_i="20958" txt_f="20959">
</offsets><xref rid="R61" ref-type="bibr"><offsets xml_i="39191" xml_f="39193" txt_i="20959" txt_f="20961">61</offsets></xref><offsets xml_i="39200" xml_f="39324" txt_i="20961" txt_f="21085"> (12 items, 5-point scale), a widely used symptom checklist of commonly experienced physical symptoms. (2) The BDS checklist</offsets><xref rid="R59" ref-type="bibr"><offsets xml_i="39356" xml_f="39358" txt_i="21085" txt_f="21087">59</offsets></xref><offsets xml_i="39365" xml_f="39586" txt_i="21087" txt_f="21308"> (25 items, 5-point scale), a symptom checklist added as a new measure for validation in adolescents. It is developed from the symptoms stated in the BDS criteria, hence evaluating symptom severity in four symptom groups.</offsets></p><p><offsets xml_i="39593" xml_f="39722" txt_i="21309" txt_f="21438">The impact of symptoms on functioning, that is, symptom interference, is evaluated by self-report and parent report using the LI.</offsets><xref rid="R44" ref-type="bibr"><offsets xml_i="39754" xml_f="39756" txt_i="21438" txt_f="21440">44</offsets></xref><offsets xml_i="39763" xml_f="39764" txt_i="21440" txt_f="21441">
</offsets><xref rid="R52" ref-type="bibr"><offsets xml_i="39796" xml_f="39798" txt_i="21441" txt_f="21443">52</offsets></xref><offsets xml_i="39805" xml_f="40233" txt_i="21443" txt_f="21871"> LI is a modified version of the Pain Interference Index (PII) (6 items, 7-point scale), a validated questionnaire for children and adolescents measuring the impact of pain in performing everyday activities and impact on, for example, mood and sleep. The modification from PII to LI is limited and represents a change in wording from ‘pain’ to ‘symptoms’. Self-reported degree of absence from school or work is being registered.</offsets></p><p><offsets xml_i="40240" xml_f="40395" txt_i="21872" txt_f="22027">Assessing symptoms of anxiety and depression brief versions of the corresponding subscales from Symptom Checklist Revised-90 are used (SCL-8, SCL-6, SCL-4)</offsets><xref rid="R58" ref-type="bibr"><offsets xml_i="40427" xml_f="40429" txt_i="22027" txt_f="22029">58</offsets></xref><offsets xml_i="40436" xml_f="40437" txt_i="22029" txt_f="22030">
</offsets><xref rid="R60" ref-type="bibr"><offsets xml_i="40469" xml_f="40474" txt_i="22030" txt_f="22035">60–62</offsets></xref><offsets xml_i="40481" xml_f="40566" txt_i="22035" txt_f="22120"> (13 items in total, 5 point scale). Level of illness worry is measured by Whiteley-7</offsets><xref rid="R63" ref-type="bibr"><offsets xml_i="40598" xml_f="40600" txt_i="22120" txt_f="22122">63</offsets></xref><offsets xml_i="40607" xml_f="40745" txt_i="22122" txt_f="22260"> (7 items, 5-point scale), a subscale of the Whiteley Index. Mental health is measured with the Mental Component Summary (MCS) from SF-36.</offsets><xref rid="R56" ref-type="bibr"><offsets xml_i="40777" xml_f="40779" txt_i="22260" txt_f="22262">56</offsets></xref><offsets xml_i="40786" xml_f="40787" txt_i="22262" txt_f="22263">
</offsets><xref rid="R57" ref-type="bibr"><offsets xml_i="40819" xml_f="40821" txt_i="22263" txt_f="22265">57</offsets></xref></p><p><offsets xml_i="40835" xml_f="40914" txt_i="22266" txt_f="22345">Subjective perception of stress is measured by the Perceived Stress Scale (PSS)</offsets><xref rid="R64" ref-type="bibr"><offsets xml_i="40946" xml_f="40948" txt_i="22345" txt_f="22347">64</offsets></xref><offsets xml_i="40955" xml_f="40956" txt_i="22347" txt_f="22348">
</offsets><xref rid="R75" ref-type="bibr"><offsets xml_i="40988" xml_f="40990" txt_i="22348" txt_f="22350">75</offsets></xref><offsets xml_i="40997" xml_f="41177" txt_i="22350" txt_f="22530"> (10 items, 5-point scale). The scale is a widely used measure of the degree to which situations in life are perceived as stressful. Danish norm data for adolescents are available.</offsets></p><p><offsets xml_i="41184" xml_f="41285" txt_i="22531" txt_f="22632">The overall impression of improvement is measured with the Patient Global Impression of Change (PGIC)</offsets><xref rid="R65" ref-type="bibr"><offsets xml_i="41317" xml_f="41319" txt_i="22632" txt_f="22634">65</offsets></xref><offsets xml_i="41326" xml_f="41504" txt_i="22634" txt_f="22812"> (1 item, 7-point scale). Answers range from ‘no change (or condition has gotten worse)’ to ‘a great deal better and a considerable improvement that has made all the difference’.</offsets></p></sec><sec id="s4c"><title><offsets xml_i="41535" xml_f="41551" txt_i="22814" txt_f="22830">Process measures</offsets></title><p><offsets xml_i="41562" xml_f="41753" txt_i="22831" txt_f="23022">The process measures evaluate specific areas hypothesised to play a role in the development and perpetuation of functional somatic symptoms, and are hence addressed directly in the treatment.</offsets></p><p><offsets xml_i="41760" xml_f="41844" txt_i="23023" txt_f="23107">Illness perception is measured by the Brief Illness Perceptions Questionnaire (BIPQ)</offsets><xref rid="R66" ref-type="bibr"><offsets xml_i="41876" xml_f="41878" txt_i="23107" txt_f="23109">66</offsets></xref><offsets xml_i="41885" xml_f="42288" txt_i="23109" txt_f="23512"> (8 items, 10-point scale and additional item regarding cause of symptoms) which has been widely used in a range of illnesses. The perception of five core components (identity, cause, timeline, consequence and cure–control) is evaluated as they together form the perception of illness. In a comparable study with adults, changes in illness perceptions partly mediated the effect of treatment on outcome.</offsets><xref rid="R76" ref-type="bibr"><offsets xml_i="42320" xml_f="42322" txt_i="23512" txt_f="23514">76</offsets></xref></p><p><offsets xml_i="42336" xml_f="42434" txt_i="23515" txt_f="23613">Illness-related behaviour is measured by the Behavioural Responses to Illness Questionnaire (BRIQ)</offsets><xref rid="R67" ref-type="bibr"><offsets xml_i="42466" xml_f="42468" txt_i="23613" txt_f="23615">67</offsets></xref><offsets xml_i="42475" xml_f="42601" txt_i="23615" txt_f="23741"> (13 item, 5-point scale). Specific illness-related behaviours have shown to be risk factors for development of FSS in adults.</offsets><xref rid="R67" ref-type="bibr"><offsets xml_i="42633" xml_f="42635" txt_i="23741" txt_f="23743">67</offsets></xref></p><p><offsets xml_i="42649" xml_f="42744" txt_i="23744" txt_f="23839">Psychological flexibility is an area specifically targeted in ACT. It is measured by the AFQ-Y8</offsets><xref rid="R53" ref-type="bibr"><offsets xml_i="42776" xml_f="42778" txt_i="23839" txt_f="23841">53</offsets></xref><offsets xml_i="42785" xml_f="42822" txt_i="23841" txt_f="23878"> (8 items, 5-point scale) and PIPS-12</offsets><xref rid="R54" ref-type="bibr"><offsets xml_i="42854" xml_f="42856" txt_i="23878" txt_f="23880">54</offsets></xref><offsets xml_i="42863" xml_f="42890" txt_i="23880" txt_f="23907"> (12 items, 7-point scale).</offsets></p></sec><sec id="s4d"><title><offsets xml_i="42921" xml_f="42956" txt_i="23909" txt_f="23944">Potential predictors and moderators</offsets></title><p><offsets xml_i="42967" xml_f="43179" txt_i="23945" txt_f="24157">Relevant demographic data and potential important predictors for outcome, for example, predisposition to functional syndromes and number and kind of life events, are obtained as part of the diagnostic assessment.</offsets><xref rid="R70" ref-type="bibr"><offsets xml_i="43211" xml_f="43213" txt_i="24157" txt_f="24159">70</offsets></xref></p><p><offsets xml_i="43227" xml_f="43336" txt_i="24160" txt_f="24269">Family functioning is assessed by the subscale on general functioning from the Family Assessment Device (FAD)</offsets><xref rid="R68" ref-type="bibr"><offsets xml_i="43368" xml_f="43370" txt_i="24269" txt_f="24271">68</offsets></xref><offsets xml_i="43377" xml_f="43378" txt_i="24271" txt_f="24272">
</offsets><xref rid="R77" ref-type="bibr"><offsets xml_i="43410" xml_f="43412" txt_i="24272" txt_f="24274">77</offsets></xref><offsets xml_i="43419" xml_f="43586" txt_i="24274" txt_f="24441"> (12 items, 4-point scale). In addition, the patient’′s attachment style is assessed dimensionally by Experience in Close Relationships—Relationship Structure (ECR-RS)</offsets><xref rid="R69" ref-type="bibr"><offsets xml_i="43618" xml_f="43620" txt_i="24441" txt_f="24443">69</offsets></xref><offsets xml_i="43627" xml_f="43653" txt_i="24443" txt_f="24469"> (9 items, 7-point scale).</offsets></p><p><offsets xml_i="43660" xml_f="43760" txt_i="24470" txt_f="24570">Credibility regarding treatment is assessed before the individual standard psychiatric consultation.</offsets><xref rid="R78" ref-type="bibr"><offsets xml_i="43792" xml_f="43794" txt_i="24570" txt_f="24572">78</offsets></xref><offsets xml_i="43801" xml_f="43955" txt_i="24572" txt_f="24726"> At end of treatment, that is, after module 9, the participants complete a standard questionnaire regarding their experience of the service at the clinic.</offsets></p><p><offsets xml_i="43962" xml_f="44096" txt_i="24727" txt_f="24861">Concomitant treatment and serious adverse events during the trial period will be registered by self-report 1 year after randomisation.</offsets></p></sec><sec id="s4e"><title><offsets xml_i="44127" xml_f="44149" txt_i="24863" txt_f="24885">Physiological measures</offsets></title><p><offsets xml_i="44160" xml_f="44258" txt_i="24886" txt_f="24984">Bodily stress response is assessed with three different measures pretreatment and post-treatment:
</offsets><list list-type="order"><list-item><p><offsets xml_i="44296" xml_f="44545" txt_i="24984" txt_f="25233">Heart rate variability as an indirect measure of the balance between the sympathetic and parasympathetic system. It is measured in various standardised situations (resting state, standing, slow breathing and valsalva) with the handheld device Vagus.</offsets><xref rid="R16" ref-type="bibr"><offsets xml_i="44577" xml_f="44579" txt_i="25233" txt_f="25235">16</offsets></xref><offsets xml_i="44586" xml_f="44587" txt_i="25235" txt_f="25236">
</offsets><xref rid="R71" ref-type="bibr"><offsets xml_i="44619" xml_f="44621" txt_i="25236" txt_f="25238">71</offsets></xref><offsets xml_i="44628" xml_f="44629" txt_i="25238" txt_f="25239">
</offsets><xref rid="R79" ref-type="bibr"><offsets xml_i="44661" xml_f="44663" txt_i="25239" txt_f="25241">79</offsets></xref></p></list-item><list-item><p><offsets xml_i="44700" xml_f="44918" txt_i="25242" txt_f="25460">Hair cortisol as a biological marker for long-term bodily stress. It is measured from two strands of hair cut close to the scalp, since the proximal 1 cm segment of hair represents the cortisol level of the past month.</offsets><xref rid="R80" ref-type="bibr"><offsets xml_i="44950" xml_f="44952" txt_i="25460" txt_f="25462">80</offsets></xref></p></list-item><list-item><p><offsets xml_i="44989" xml_f="45261" txt_i="25463" txt_f="25735">Biomarkers for inflammatory and oxidative stress (including interleukin 6 (IL-6), tumour necrosis factor-α, high-sensitive C reactive protein, IL-1, neopterin, CD163, heme oxygenase-1 (HO1), monocyte chemoattractant protein-1 (MCP1) as well as newer proteo-based markers).</offsets><xref rid="R81" ref-type="bibr"><offsets xml_i="45293" xml_f="45298" txt_i="25735" txt_f="25740">81–84</offsets></xref></p></list-item></list></p></sec><sec id="s4f"><title><offsets xml_i="45359" xml_f="45376" txt_i="25743" txt_f="25760">Physical activity</offsets></title><p><offsets xml_i="45387" xml_f="45532" txt_i="25761" txt_f="25906">Level of physical activity is assessed pretreatment and post-treatment by anthropometric measurements with an accelerometer (Actigraph wGT3X-BT).</offsets><xref rid="R72" ref-type="bibr"><offsets xml_i="45564" xml_f="45566" txt_i="25906" txt_f="25908">72</offsets></xref><offsets xml_i="45573" xml_f="45659" txt_i="25908" txt_f="25994"> The accelerometer is worn on the right hip 24 hours-a-day for seven consecutive days.</offsets></p><p><offsets xml_i="45666" xml_f="45920" txt_i="25995" txt_f="26249">A specific protocol for evaluation of physiological measures and physical activity will be made specifying hypotheses and analytical strategies. A large ongoing epidemiological study in Denmark (DanFunD) will be available for later comparison of results.</offsets><xref rid="R85" ref-type="bibr"><offsets xml_i="45952" xml_f="45954" txt_i="26249" txt_f="26251">85</offsets></xref></p></sec></sec><sec id="s5"><title><offsets xml_i="45997" xml_f="46019" txt_i="26254" txt_f="26276">Sample size estimation</offsets></title><p><offsets xml_i="46030" xml_f="46267" txt_i="26277" txt_f="26514">Power estimation is based on the primary hypothesis regarding changes in self-reported physical health measured with the SF-36 aggregate score. Given the efficacy in a previous RCT study of ACT in adolescents with chronic functional pain</offsets><xref rid="R44" ref-type="bibr"><offsets xml_i="46299" xml_f="46301" txt_i="26514" txt_f="26516">44</offsets></xref><offsets xml_i="46308" xml_f="46405" txt_i="26516" txt_f="26613"> as well as data on a subgroup of patients under 30 years from another RCT study of CBT with BDS,</offsets><xref rid="R39" ref-type="bibr"><offsets xml_i="46437" xml_f="46439" txt_i="26613" txt_f="26615">39</offsets></xref><offsets xml_i="46446" xml_f="47011" txt_i="26615" txt_f="27180"> an improvement of self-reported physical health is estimated to be maximum three points (from 39 to 42) in the control group and at least five points (from 39 to 44) in the ACT group from baseline to 12 months after randomisation. The baseline value assumes an SD of 8 referring to the defined groups of patients. Using a random-effects model in a simulation setting shows that in order to statistically detect such a difference in improvement (test of no interaction), given a two-sided α of 0.05 and with 95% power, we need to allocate 60 patients to each group.</offsets></p></sec><sec id="s6"><title><offsets xml_i="47041" xml_f="47061" txt_i="27182" txt_f="27202">Statistical analysis</offsets></title><p><offsets xml_i="47072" xml_f="47574" txt_i="27203" txt_f="27705">The efficacy of the ACT treatment will be evaluated on an intention-to-treat basis by means of random-effects model regression analysis adjusted for prognostic important baseline characteristics. The main efficacy analysis will pertain to the data obtained at 12 months follow-up. Baseline characteristics will be tabulated by treatment modality in order to evaluate success of randomisation. To judge possible bias due to missing data, a random-effect model on multiple imputed data will be performed.</offsets></p><p><offsets xml_i="47581" xml_f="47825" txt_i="27706" txt_f="27950">An explorative mediation analysis will be performed to investigate to what extent the intervention can affect the primary outcome through each of the process measures. The analytical strategy previously used in a large-scale trial will be used.</offsets><xref rid="R86" ref-type="bibr"><offsets xml_i="47857" xml_f="47859" txt_i="27950" txt_f="27952">86</offsets></xref></p></sec><sec id="s7"><title><offsets xml_i="47896" xml_f="47909" txt_i="27954" txt_f="27967">Dissemination</offsets></title><p><offsets xml_i="47920" xml_f="48018" txt_i="27968" txt_f="28066">Results will be reported according to the CONSORT statement for non-pharmacological interventions,</offsets><xref rid="R87" ref-type="bibr"><offsets xml_i="48050" xml_f="48052" txt_i="28066" txt_f="28068">87</offsets></xref><offsets xml_i="48059" xml_f="48276" txt_i="28068" txt_f="28285"> and will be submitted for publication in peer-reviewed English language journals. Positive, inconclusive and negative findings will be published. Trial findings will also be disseminated through conference abstracts.</offsets></p></sec><sec id="s8"><title><offsets xml_i="48306" xml_f="48336" txt_i="28287" txt_f="28317">Data monitoring and management</offsets></title><p><offsets xml_i="48347" xml_f="48848" txt_i="28318" txt_f="28819">This trial is considered a minimal risk study and hence a data and monitoring committee has not been established. Questionnaires are administered electronically and saved in an online database. The database is secured with a password-protected access system, and access to files is limited to research staff that requires direct access. Baseline information obtained during assessment is registered in a Case Report Form (CRF). All CRFs are stored in locked file cabinets in areas with limited access.</offsets></p></sec><sec sec-type="discussion" id="s9"><title><offsets xml_i="48900" xml_f="48910" txt_i="28821" txt_f="28831">Discussion</offsets></title><p><offsets xml_i="48921" xml_f="49399" txt_i="28832" txt_f="29310">Adolescents with FSS are at risk of continuity of physical problems into adulthood implying reduced quality of life due to potential functional impairment, social withdrawal, lack of education and incapacity to work. To the best of our knowledge, this study will be one of the first larger randomised clinical trials, evaluating the efficacy of a group-based treatment for adolescents with a range of FSS grouped under the unifying diagnosis of multiorgan BDS compared with EUC.</offsets></p><p><offsets xml_i="49406" xml_f="50748" txt_i="29311" txt_f="30653">Our study design has some limitations. First is the lack of comparison with an evidence-based control treatment. However, since the aim of this study is to compare ACT group therapy to the best treatment available (ie, EUC), we use a pragmatic design that offers systematic clinical assessment and an individual treatment plan also to patients in the usual care arm. Also, a unified treatment for adolescents with a range of FSS has not been tested before. Second, blinding is not possible to the clinician providing the standard psychiatric consultation. However, this is a general problem in trials of behavioural interventions. Third, the study design does not allow us to determine which treatment components are most important in achieving change. Accordingly, our aim is to assess whether the whole complex intervention as delivered is more effective than EUC in improving physical health. Fourth, the assessment and treatment are carried out in a specialised setting, which might not guarantee that the treatment, if proven successful, will work in everyday clinical practice across different populations, clinical contexts, etc. Finally, the results from the study cannot automatically be applied to younger adolescents given the developmental perspective, with multiple symptoms being less common in children and younger adolescents.</offsets></p><p><offsets xml_i="50755" xml_f="51026" txt_i="30654" txt_f="30925">Important strengths of the study are the evaluation of potential psychosocial and biological predictors and moderators of outcomes. Furthermore, all patients are given a thorough assessment providing them with a positive and evidence-based understanding of their illness,</offsets><xref rid="R88" ref-type="bibr"><offsets xml_i="51058" xml_f="51060" txt_i="30925" txt_f="30927">88</offsets></xref><offsets xml_i="51067" xml_f="51068" txt_i="30927" txt_f="30928">
</offsets><xref rid="R89" ref-type="bibr"><offsets xml_i="51100" xml_f="51102" txt_i="30928" txt_f="30930">89</offsets></xref><offsets xml_i="51109" xml_f="51256" txt_i="30930" txt_f="31077"> and the treatment model is developed based on treatments with proven effect for both paediatric and adult patients with FSS and related disorders.</offsets><xref rid="R39" ref-type="bibr"><offsets xml_i="51288" xml_f="51290" txt_i="31077" txt_f="31079">39</offsets></xref><offsets xml_i="51297" xml_f="51298" txt_i="31079" txt_f="31080">
</offsets><xref rid="R40" ref-type="bibr"><offsets xml_i="51330" xml_f="51332" txt_i="31080" txt_f="31082">40</offsets></xref><offsets xml_i="51339" xml_f="51340" txt_i="31082" txt_f="31083">
</offsets><xref rid="R44" ref-type="bibr"><offsets xml_i="51372" xml_f="51374" txt_i="31083" txt_f="31085">44</offsets></xref></p><p><offsets xml_i="51388" xml_f="51591" txt_i="31086" txt_f="31289">Bias is minimised by the use of a manualised treatment, different therapists, valid outcome measures, multiple assessment points and by predefining and publishing all outcome measures before study start.</offsets></p><p><offsets xml_i="51598" xml_f="51907" txt_i="31290" txt_f="31599">Anticipated difficulties conducting the study include recruitment problems due to stringent inclusion and exclusion criteria as well as lack of knowledge of available service for adolescents and social prejudices in terms of receiving psychiatric diagnosis and psychological treatment for functional symptoms.</offsets><xref rid="R8" ref-type="bibr"><offsets xml_i="51938" xml_f="51939" txt_i="31599" txt_f="31600">8</offsets></xref></p><p><offsets xml_i="51953" xml_f="52261" txt_i="31601" txt_f="31909">In conclusion, this study will provide important information about efficacy, processes of change and moderators. If the treatment is successful, it will improve the quality of life of adolescents with FSS and may, over the life course, lead to substantial savings in both healthcare costs and societal costs.</offsets></p></sec></body><back><fn-group><fn><p><bold>Contributors:</bold> KHK took part in designing of the study, drafted the initial manuscript and prepared the final manuscript as submitted. AS took part in developing the research idea and in designing of the study, contributed with data for statistical power analysis and critically revised the manuscript. RKW took part in designing of the study, contributed with data for statistical power analysis and critically revised the manuscript. PF took part in developing of the research idea and critically revised the manuscript. EØ took part in the statistical design of the study, made the power analysis and description of the statistical method and critically revised the manuscript. CUR came up with the original research idea, took part in designing of the study, drafted the initial treatment protocol and critically revised the manuscript. All the authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.</p></fn><fn><p><bold>Funding:</bold> This study is supported by TrygFonden (grant number 100408) and the Danish Medical Associations Research Fund (grant number 2013-5480/912523-63).</p></fn><fn><p><bold>Disclaimer:</bold> None of the funding sources have authority over any of the study activities.</p></fn><fn><p><bold>Competing interests:</bold> None declared.</p></fn><fn><p><bold>Ethics approval:</bold> The project will be conducted in accordance with Helsinki Declaration II. Approval has been obtained from the Science Ethics Committee of the Central Denmark Region (journal number 1-10-72-181-14) and the Danish Data Protection (reference number 2007-58-0010; application number 1-16-02-290-14).</p></fn><fn><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korterink</surname><given-names>JJ</given-names></name>, <name><surname>Diederen</surname><given-names>K</given-names></name>, <name><surname>Benninga</surname><given-names>MA</given-names></name><etal></etal></person-group>
<article-title>Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis</article-title>. <source>PLoS ONE</source>
<year>2015</year>;<volume>10</volume>:<fpage>e0126982</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0126982">doi:10.1371/journal.pone.0126982</ext-link><pub-id pub-id-type="pmid">25992621</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashikar-Zuck</surname><given-names>S</given-names></name>, <name><surname>Ting</surname><given-names>TV</given-names></name></person-group>
<article-title>Juvenile fibromyalgia: current status of research and future developments</article-title>. <source>Nat Rev Rheumatol</source>
<year>2014</year>;<volume>10</volume>:<fpage>89</fpage>–<lpage>96</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrrheum.2013.177">doi:10.1038/nrrheum.2013.177</ext-link><pub-id pub-id-type="pmid">24275966</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijhof</surname><given-names>SL</given-names></name>, <name><surname>Maijer</surname><given-names>K</given-names></name>, <name><surname>Bleijenberg</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Adolescent chronic fatigue syndrome: prevalence, incidence, and morbidity</article-title>. <source>Pediatrics</source>
<year>2011</year>;<volume>127</volume>:<fpage>e1169</fpage>–<lpage>75</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2010-1147">doi:10.1542/peds.2010-1147</ext-link><pub-id pub-id-type="pmid">21502228</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garralda</surname><given-names>ME</given-names></name></person-group>
<article-title>Unexplained physical complaints</article-title>. <source>Pediatr Clin North Am</source>
<year>2011</year>;<volume>58</volume>:<fpage>803</fpage>–<lpage>13</lpage>, <comment>ix</comment>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pcl.2011.06.002">doi:10.1016/j.pcl.2011.06.002</ext-link><pub-id pub-id-type="pmid">21855708</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname><given-names>M</given-names></name>, <name><surname>Kramer</surname><given-names>T</given-names></name>, <name><surname>Hickey</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Assessment of somatic symptoms in British secondary school children using the Children's Somatization Inventory (CSI)</article-title>. <source>J Pediatr Psychol</source>
<year>2009</year>;<volume>34</volume>:<fpage>989</fpage>–<lpage>98</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jpepsy/jsp005">doi:10.1093/jpepsy/jsp005</ext-link><pub-id pub-id-type="pmid">19223276</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eminson</surname><given-names>DM</given-names></name></person-group>
<article-title>Medically unexplained symptoms in children and adolescents</article-title>. <source>Clin Psychol Rev</source>
<year>2007</year>;<volume>27</volume>:<fpage>855</fpage>–<lpage>71</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cpr.2007.07.007">doi:10.1016/j.cpr.2007.07.007</ext-link><pub-id pub-id-type="pmid">17804131</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Härmä</surname><given-names>AM</given-names></name>, <name><surname>Kaltiala-Heino</surname><given-names>R</given-names></name>, <name><surname>Rimpelä</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Are adolescents with frequent pain symptoms more depressed?</article-title>
<source>Scand J Prim Health Care</source>
<year>2002</year>;<volume>20</volume>:<fpage>92</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="pmid">12184720</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Garralda</surname><given-names>ME</given-names></name>, <name><surname>Rask</surname><given-names>CU</given-names></name></person-group>
<article-title>Somatoform and related disorders</article-title>. In: <person-group person-group-type="editor"><name><surname>Thapar</surname><given-names>A</given-names></name>, <name><surname>Pine</surname><given-names>DS</given-names></name>, <name><surname>Leckman</surname><given-names>JF</given-names></name><etal></etal></person-group>, eds. <source>Rutter's child and adolescent psychiatry</source>. <edition>6th edn</edition>
<publisher-name>Wiley-Blackwell</publisher-name>, <year>2015</year>:<fpage>1038</fpage>.</mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashikar-Zuck</surname><given-names>S</given-names></name>, <name><surname>Cunningham</surname><given-names>N</given-names></name>, <name><surname>Sil</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood</article-title>. <source>Pediatrics</source>
<year>2014</year>;<volume>133</volume>:<fpage>e592</fpage>–<lpage>600</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2013-2220">doi:10.1542/peds.2013-2220</ext-link><pub-id pub-id-type="pmid">24567017</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horst</surname><given-names>S</given-names></name>, <name><surname>Shelby</surname><given-names>G</given-names></name>, <name><surname>Anderson</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Predicting persistence of functional abdominal pain from childhood into young adulthood</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2014</year>;<volume>12</volume>:<fpage>2026</fpage>–<lpage>32</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cgh.2014.03.034">doi:10.1016/j.cgh.2014.03.034</ext-link><pub-id pub-id-type="pmid">24732284</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhausen</surname><given-names>HC</given-names></name>, <name><surname>Winkler Metzke</surname><given-names>C</given-names></name></person-group>
<article-title>Continuity of functional-somatic symptoms from late childhood to young adulthood in a community sample</article-title>. <source>J Child Psychol Psychiatry</source>
<year>2007</year>;<volume>48</volume>:<fpage>508</fpage>–<lpage>13</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1469-7610.2006.01721.x">doi:10.1111/j.1469-7610.2006.01721.x</ext-link><pub-id pub-id-type="pmid">17501732</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perquin</surname><given-names>CW</given-names></name>, <name><surname>Hunfeld</surname><given-names>JA</given-names></name>, <name><surname>Hazebroek-Kampschreur</surname><given-names>AA</given-names></name><etal></etal></person-group>
<article-title>Insights in the use of health care services in chronic benign pain in childhood and adolescence</article-title>. <source>Pain</source>
<year>2001</year>;<volume>94</volume>:<fpage>205</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">11690734</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssens</surname><given-names>KA</given-names></name>, <name><surname>Oldehinkel</surname><given-names>AJ</given-names></name>, <name><surname>Verhulst</surname><given-names>FC</given-names></name><etal></etal></person-group>
<article-title>Symptom-specific associations between low cortisol responses and functional somatic symptoms: the TRAILS study</article-title>. <source>Psychoneuroendocrinology</source>
<year>2012</year>;<volume>37</volume>:<fpage>332</fpage>–<lpage>40</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.psyneuen.2011.06.016">doi:10.1016/j.psyneuen.2011.06.016</ext-link><pub-id pub-id-type="pmid">21803502</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tak</surname><given-names>LM</given-names></name>, <name><surname>Janssens</surname><given-names>KA</given-names></name>, <name><surname>Dietrich</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Age-specific associations between cardiac vagal activity and functional somatic symptoms: a population-based study</article-title>. <source>Psychother Psychosom</source>
<year>2010</year>;<volume>79</volume>:<fpage>179</fpage>–<lpage>87</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000296136">doi:10.1159/000296136</ext-link><pub-id pub-id-type="pmid">20234148</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meeus</surname><given-names>M</given-names></name>, <name><surname>Nijs</surname><given-names>J</given-names></name></person-group>
<article-title>Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome</article-title>. <source>Clin Rheumatol</source>
<year>2007</year>;<volume>26</volume>:<fpage>465</fpage>–<lpage>73</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10067-006-0433-9">doi:10.1007/s10067-006-0433-9</ext-link><pub-id pub-id-type="pmid">17115100</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadopoulos</surname><given-names>AS</given-names></name>, <name><surname>Cleare</surname><given-names>AJ</given-names></name></person-group>
<article-title>Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome</article-title>. <source>Nat Rev Endocrinol</source>
<year>2011</year>;<volume>8</volume>:<fpage>22</fpage>–<lpage>32</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrendo.2011.153">doi:10.1038/nrendo.2011.153</ext-link><pub-id pub-id-type="pmid">21946893</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schröder</surname><given-names>A</given-names></name>, <name><surname>Fink</surname><given-names>P</given-names></name></person-group>
<article-title>Functional somatic syndromes and somatoform disorders in special psychosomatic units: organizational aspects and evidence-based treatment</article-title>. <source>Psychiatr Clin North Am</source>
<year>2011</year>;<volume>34</volume>:<fpage>673</fpage>–<lpage>87</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.psc.2011.05.008">doi:10.1016/j.psc.2011.05.008</ext-link><pub-id pub-id-type="pmid">21889686</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grøholt</surname><given-names>EK</given-names></name>, <name><surname>Stigum</surname><given-names>H</given-names></name>, <name><surname>Nordhagen</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Recurrent pain in children, socio-economic factors and accumulation in families</article-title>. <source>Eur J Epidemiol</source>
<year>2003</year>;<volume>18</volume>:<fpage>965</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">14598927</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oster</surname><given-names>J</given-names></name></person-group>
<article-title>Recurrent abdominal pain, headache and limb pains in children and adolescents</article-title>. <source>Pediatrics</source>
<year>1972</year>;<volume>50</volume>:<fpage>429</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">5056416</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perquin</surname><given-names>CW</given-names></name>, <name><surname>Hazebroek-Kampschreur</surname><given-names>AA</given-names></name>, <name><surname>Hunfeld</surname><given-names>JA</given-names></name><etal></etal></person-group>
<article-title>Pain in children and adolescents: a common experience</article-title>. <source>Pain</source>
<year>2000</year>;<volume>87</volume>:<fpage>51</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">10863045</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask</surname><given-names>CU</given-names></name>, <name><surname>Ørnbøl</surname><given-names>E</given-names></name>, <name><surname>Fink</surname><given-names>PK</given-names></name><etal></etal></person-group>
<article-title>Functional somatic symptoms and consultation patterns in 5- to 7-year-olds</article-title>. <source>Pediatrics</source>
<year>2013</year>;<volume>132</volume>:<fpage>e459</fpage>–<lpage>67</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2013-0159">doi:10.1542/peds.2013-0159</ext-link><pub-id pub-id-type="pmid">23837183</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budtz-Lilly</surname><given-names>A</given-names></name>, <name><surname>Schröder</surname><given-names>A</given-names></name>, <name><surname>Rask</surname><given-names>MT</given-names></name><etal></etal></person-group>
<article-title>Bodily distress syndrome: a new diagnosis for functional disorders in primary care?</article-title>
<source>BMC Fam Pract</source>
<year>2015</year>;<volume>16</volume>:<fpage>180</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/s12875-015-0393-8">doi:10.1186/s12875-015-0393-8</ext-link><pub-id pub-id-type="pmid">26669977</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creed</surname><given-names>FH</given-names></name>, <name><surname>Tomenson</surname><given-names>B</given-names></name>, <name><surname>Chew-Graham</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Multiple somatic symptoms predict impaired health status in functional somatic syndromes</article-title>. <source>Int J Behav Med</source>
<year>2013</year>;<volume>20</volume>:<fpage>194</fpage>–<lpage>205</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12529-012-9257-y">doi:10.1007/s12529-012-9257-y</ext-link><pub-id pub-id-type="pmid">22932928</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rask</surname><given-names>M</given-names></name>, <name><surname>Ørnbøl</surname><given-names>E</given-names></name>, <name><surname>Rosendal</surname><given-names>M</given-names></name><etal></etal></person-group>
<comment><italic>Long-term outcome of bodily distress syndrome in primary care: a follow-up study on healthcare costs, work disability, and self-rated health</italic></comment>
<source>Psychoso Med</source>. <comment>In press. <ext-link ext-link-type="uri" xlink:href="http://dx.doi:10.1097/PSY.0000000000000405">doi:10.1097/PSY.0000000000000405</ext-link></comment><ext-link ext-link-type="uri" xlink:href="http://dx.doi:10.1097/PSY.0000000000000405">doi:10.1097/PSY.0000000000000405</ext-link></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>P</given-names></name>, <name><surname>Toft</surname><given-names>T</given-names></name>, <name><surname>Hansen</surname><given-names>MS</given-names></name><etal></etal></person-group>
<article-title>Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients</article-title>. <source>Psychosom Med</source>
<year>2007</year>;<volume>69</volume>:<fpage>30</fpage>–<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PSY.0b013e31802e46eb">doi:10.1097/PSY.0b013e31802e46eb</ext-link><pub-id pub-id-type="pmid">17244846</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>P</given-names></name>, <name><surname>Schröder</surname><given-names>A</given-names></name></person-group>
<article-title>One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders</article-title>. <source>J Psychosom Res</source>
<year>2010</year>;<volume>68</volume>:<fpage>415</fpage>–<lpage>26</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jpsychores.2010.02.004">doi:10.1016/j.jpsychores.2010.02.004</ext-link><pub-id pub-id-type="pmid">20403500</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glombiewski</surname><given-names>JA</given-names></name>, <name><surname>Sawyer</surname><given-names>AT</given-names></name>, <name><surname>Gutermann</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Psychological treatments for fibromyalgia: a meta-analysis</article-title>. <source>Pain</source>
<year>2010</year>;<volume>151</volume>:<fpage>280</fpage>–<lpage>95</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pain.2010.06.011">doi:10.1016/j.pain.2010.06.011</ext-link><pub-id pub-id-type="pmid">20727679</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>PD</given-names></name>, <name><surname>Goldsmith</surname><given-names>KA</given-names></name>, <name><surname>Johnson</surname><given-names>AL</given-names></name><etal></etal></person-group>
<article-title>Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial</article-title>. <source>Lancet</source>
<year>2011</year>;<volume>377</volume>:<fpage>823</fpage>–<lpage>36</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(11)60096-2">doi:10.1016/S0140-6736(11)60096-2</ext-link><pub-id pub-id-type="pmid">21334061</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinstäuber</surname><given-names>M</given-names></name>, <name><surname>Witthöft</surname><given-names>M</given-names></name>, <name><surname>Hiller</surname><given-names>W</given-names></name></person-group>
<article-title>Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis</article-title>. <source>Clin Psychol Rev</source>
<year>2011</year>;<volume>31</volume>:<fpage>146</fpage>–<lpage>60</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cpr.2010.09.001">doi:10.1016/j.cpr.2010.09.001</ext-link><pub-id pub-id-type="pmid">20920834</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zijdenbos</surname><given-names>IL</given-names></name>, <name><surname>de Wit</surname><given-names>NJ</given-names></name>, <name><surname>van der Heijden</surname><given-names>GJ</given-names></name><etal></etal></person-group>
<article-title>Psychological treatments for the management of irritable bowel syndrome</article-title>. <source>Cochrane Database Syst Rev</source>
<year>2009</year>;<issue>(1)</issue>:<fpage>CD006442</fpage>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/14651858.CD006442.pub2">doi:10.1002/14651858.CD006442.pub2</ext-link><pub-id pub-id-type="pmid">19160286</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husain</surname><given-names>K</given-names></name>, <name><surname>Browne</surname><given-names>T</given-names></name>, <name><surname>Chalder</surname><given-names>T</given-names></name></person-group>
<article-title>A review of psychological models and interventions for medically unexplained somatic symptoms in children</article-title>. <source>Child Adolesc Ment Health</source>
<year>2007</year>;<volume>12</volume>:<fpage>2</fpage>–<lpage>7</lpage>.</mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>RL</given-names></name>, <name><surname>Langer</surname><given-names>SL</given-names></name>, <name><surname>Walker</surname><given-names>LS</given-names></name><etal></etal></person-group>
<article-title>Cognitive-behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms</article-title>. <source>Am J Gastroenterol</source>
<year>2010</year>;<volume>105</volume>:<fpage>946</fpage>–<lpage>56</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ajg.2010.106">doi:10.1038/ajg.2010.106</ext-link><pub-id pub-id-type="pmid">20216531</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robins</surname><given-names>PM</given-names></name>, <name><surname>Smith</surname><given-names>SM</given-names></name>, <name><surname>Glutting</surname><given-names>JJ</given-names></name><etal></etal></person-group>
<article-title>A randomized controlled trial of a cognitive-behavioral family intervention for pediatric recurrent abdominal pain</article-title>. <source>J Pediatr Psychol</source>
<year>2005</year>;<volume>30</volume>:<fpage>397</fpage>–<lpage>408</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jpepsy/jsi063">doi:10.1093/jpepsy/jsi063</ext-link><pub-id pub-id-type="pmid">15944167</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijhof</surname><given-names>SL</given-names></name>, <name><surname>Bleijenberg</surname><given-names>G</given-names></name>, <name><surname>Uiterwaal</surname><given-names>CS</given-names></name><etal></etal></person-group>
<article-title>Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial</article-title>. <source>Lancet</source>
<year>2012</year>;<volume>379</volume>:<fpage>1412</fpage>–<lpage>18</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(12)60025-7">doi:10.1016/S0140-6736(12)60025-7</ext-link><pub-id pub-id-type="pmid">22385683</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palermo</surname><given-names>TM</given-names></name>, <name><surname>Eccleston</surname><given-names>C</given-names></name>, <name><surname>Lewandowski</surname><given-names>AS</given-names></name><etal></etal></person-group>
<article-title>Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: an updated meta-analytic review</article-title>. <source>Pain</source>
<year>2010</year>;<volume>148</volume>:<fpage>387</fpage>–<lpage>97</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pain.2009.10.004">doi:10.1016/j.pain.2009.10.004</ext-link><pub-id pub-id-type="pmid">19910118</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashikar-Zuck</surname><given-names>S</given-names></name>, <name><surname>Swain</surname><given-names>NF</given-names></name>, <name><surname>Jones</surname><given-names>BA</given-names></name><etal></etal></person-group>
<article-title>Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome</article-title>. <source>J Rheumatol</source>
<year>2005</year>;<volume>32</volume>:<fpage>1594</fpage>–<lpage>602</lpage>.<pub-id pub-id-type="pmid">16078340</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schröder</surname><given-names>A</given-names></name>, <name><surname>Sharpe</surname><given-names>M</given-names></name>, <name><surname>Fink</surname><given-names>P</given-names></name></person-group>
<article-title>Medically unexplained symptom management</article-title>. <source>Lancet Psychiatry</source>
<year>2015</year>;<volume>2</volume>:<fpage>587</fpage>–<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S2215-0366(15)00233-3">doi:10.1016/S2215-0366(15)00233-3</ext-link><pub-id pub-id-type="pmid">26303546</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>P</given-names></name>, <name><surname>Burton</surname><given-names>C</given-names></name>, <name><surname>de Bie</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Current state of management and organisation of care in Medically unexplained symptoms, somatisation and bodily distress</article-title>. In: <person-group person-group-type="editor"><name><surname>Creed</surname><given-names>F</given-names></name>, <name><surname>Henningsen</surname><given-names>P</given-names></name>, <name><surname>Fink</surname><given-names>P</given-names></name></person-group>, eds. <source>Developing better clinical services</source>. <publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>, <year>2011</year>.</mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schröder</surname><given-names>A</given-names></name>, <name><surname>Rehfeld</surname><given-names>E</given-names></name>, <name><surname>Ornbøl</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial</article-title>. <source>Br J Psychiatry</source>
<year>2012</year>;<volume>200</volume>:<fpage>499</fpage>–<lpage>507</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1192/bjp.bp.111.098681">doi:10.1192/bjp.bp.111.098681</ext-link><pub-id pub-id-type="pmid">22539780</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fjorback</surname><given-names>LO</given-names></name>, <name><surname>Arendt</surname><given-names>M</given-names></name>, <name><surname>Ornbøl</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up</article-title>. <source>J Psychosom Res</source>
<year>2013</year>;<volume>74</volume>:<fpage>31</fpage>–<lpage>40</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jpsychores.2012.09.006">doi:10.1016/j.jpsychores.2012.09.006</ext-link><pub-id pub-id-type="pmid">23272986</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname><given-names>WA</given-names></name>, <name><surname>Lobato</surname><given-names>D</given-names></name>, <name><surname>Engel</surname><given-names>R</given-names></name></person-group>
<article-title>Review of group interventions for pediatric chronic conditions</article-title>. <source>J Pediatr Psychol</source>
<year>2001</year>;<volume>26</volume>:<fpage>435</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">11553698</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kichler</surname><given-names>JC</given-names></name>, <name><surname>Kaugars</surname><given-names>AS</given-names></name>, <name><surname>Marik</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Effectiveness of groups for adolescents with type 1 diabetes mellitus and their parents</article-title>. <source>Fam Syst Health</source>
<year>2013</year>;<volume>31</volume>:<fpage>280</fpage>–<lpage>93</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1037/a0033039">doi:10.1037/a0033039</ext-link><pub-id pub-id-type="pmid">23957874</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>GN</given-names></name>, <name><surname>DeBar</surname><given-names>LL</given-names></name></person-group>
<article-title>Group cognitive-behavioral treatment for adolescent depression</article-title>. In: <person-group person-group-type="editor"><name><surname>Weisz</surname><given-names>J</given-names></name>, <name><surname>Kazdin</surname><given-names>A</given-names></name></person-group>, eds. <source>Evidence-based psychotherapies for children and adolescents</source>. <edition>2nd edn</edition>
<publisher-loc>New York</publisher-loc>: <publisher-name>The Guilford Press</publisher-name>, <year>2010</year>:<fpage>111</fpage>, <comment>112, 121</comment>.</mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wicksell</surname><given-names>RK</given-names></name>, <name><surname>Melin</surname><given-names>L</given-names></name>, <name><surname>Lekander</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Evaluating the effectiveness of exposure and acceptance strategies to improve functioning and quality of life in longstanding pediatric pain—a randomized controlled trial</article-title>. <source>Pain</source>
<year>2009</year>;<volume>141</volume>:<fpage>248</fpage>–<lpage>57</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pain.2008.11.006">doi:10.1016/j.pain.2008.11.006</ext-link><pub-id pub-id-type="pmid">19108951</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauntlett-Gilbert</surname><given-names>J</given-names></name>, <name><surname>Connell</surname><given-names>H</given-names></name>, <name><surname>Clinch</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Acceptance and values-based treatment of adolescents with chronic pain: outcomes and their relationship to acceptance</article-title>. <source>J Pediatr Psychol</source>
<year>2013</year>;<volume>38</volume>:<fpage>72</fpage>–<lpage>81</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jpepsy/jss098">doi:10.1093/jpepsy/jss098</ext-link><pub-id pub-id-type="pmid">23071352</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>SC</given-names></name>, <name><surname>Bissett</surname><given-names>RT</given-names></name>, <name><surname>Korn</surname><given-names>Z</given-names></name><etal></etal></person-group>
<article-title>The impact of acceptance versus control rationales on pain tolerance</article-title>. <source>Psychol Rec</source>
<year>2012</year>;<volume>49</volume>:<fpage>3</fpage>.</mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCracken</surname><given-names>LM</given-names></name>, <name><surname>Eccleston</surname><given-names>C</given-names></name></person-group>
<article-title>Coping or acceptance: what to do about chronic pain?</article-title>
<source>Pain</source>
<year>2003</year>;<volume>105</volume>:<fpage>197</fpage>–<lpage>204</lpage>.<pub-id pub-id-type="pmid">14499436</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>SC</given-names></name>, <name><surname>Luoma</surname><given-names>JB</given-names></name>, <name><surname>Bond</surname><given-names>FW</given-names></name><etal></etal></person-group>
<article-title>Acceptance and commitment therapy: model, processes and outcomes</article-title>. <source>Behav Res Ther</source>
<year>2006</year>;<volume>44</volume>:<fpage>1</fpage>–<lpage>25</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.brat.2005.06.006">doi:10.1016/j.brat.2005.06.006</ext-link><pub-id pub-id-type="pmid">16300724</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Houdenhove</surname><given-names>B</given-names></name>, <name><surname>Luyten</surname><given-names>P</given-names></name></person-group>
<article-title>Customizing treatment of chronic fatigue syndrome and fibromyalgia: the role of perpetuating factors</article-title>. <source>Psychosomatics</source>
<year>2008</year>;<volume>49</volume>:<fpage>470</fpage>–<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1176/appi.psy.49.6.470">doi:10.1176/appi.psy.49.6.470</ext-link><pub-id pub-id-type="pmid">19122123</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>JK</given-names></name>, <name><surname>Babor</surname><given-names>T</given-names></name>, <name><surname>Brugha</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>SCAN: Schedules for Clinical Assessment in Neuropsychiatry</article-title>. <source>Arch Gen Psychiatry</source>
<year>1990</year>;<volume>47</volume>:<fpage>589</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">2190539</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>R</given-names></name>, <name><surname>Ford</surname><given-names>T</given-names></name>, <name><surname>Richards</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology</article-title>. <source>J Child Psychol Psychiatry</source>
<year>2000</year>;<volume>41</volume>:<fpage>645</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">10946756</pub-id></mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmström</surname><given-names>L</given-names></name>, <name><surname>Kemani</surname><given-names>MK</given-names></name>, <name><surname>Kanstrup</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Evaluating the Statistical Properties of the Pain Interference Index in Children and Adolescents with Chronic Pain</article-title>. <source>J Dev Behav Pediatr</source>
<year>2015</year>;<volume>36</volume>:<fpage>450</fpage>–<lpage>4</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/DBP.0000000000000191">doi:10.1097/DBP.0000000000000191</ext-link><pub-id pub-id-type="pmid">26154714</pub-id></mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>LA</given-names></name>, <name><surname>Lambert</surname><given-names>W</given-names></name>, <name><surname>Baer</surname><given-names>RA</given-names></name></person-group>
<article-title>Psychological inflexibility in childhood and adolescence: development and evaluation of the Avoidance and Fusion Questionnaire for Youth</article-title>. <source>Psychol Assess</source>
<year>2008</year>;<volume>20</volume>:<fpage>93</fpage>–<lpage>102</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1037/1040-3590.20.2.93">doi:10.1037/1040-3590.20.2.93</ext-link><pub-id pub-id-type="pmid">18557686</pub-id></mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wicksell</surname><given-names>RK</given-names></name>, <name><surname>Lekander</surname><given-names>M</given-names></name>, <name><surname>Sorjonen</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>The Psychological Inflexibility in Pain Scale (PIPS)—statistical properties and model fit of an instrument to assess change processes in pain related disability</article-title>. <source>Eur J Pain</source>
<year>2010</year>;<volume>14</volume>:<fpage>771.e1</fpage>–<lpage>14</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejpain.2009.11.015">doi:10.1016/j.ejpain.2009.11.015</ext-link><pub-id pub-id-type="pmid">20106685</pub-id></mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaton</surname><given-names>DE</given-names></name>, <name><surname>Bombardier</surname><given-names>C</given-names></name>, <name><surname>Guillemin</surname><given-names>F</given-names></name><etal></etal></person-group>
<article-title>Guidelines for the process of cross-cultural adaptation of self-report measures</article-title>. <source>Spine (Phila Pa 1976)</source>
<year>2000</year>;<volume>25</volume>:<fpage>3186</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">11124735</pub-id></mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Bjørner</surname><given-names>J</given-names></name>, <name><surname>Damsgaard</surname><given-names>M</given-names></name>, <name><surname>Watt</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Dansk manual til SF-36: Et spørgeskema om helbredsstatus. Danish Manual</article-title>. <year>1997</year>.</mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjorner</surname><given-names>JB</given-names></name>, <name><surname>Damsgaard</surname><given-names>MT</given-names></name>, <name><surname>Watt</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Tests of data quality, scaling assumptions, and reliability of the Danish SF-36</article-title>. <source>J Clin Epidemiol</source>
<year>1998</year>;<volume>51</volume>:<fpage>1001</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">9817118</pub-id></mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derogatis</surname><given-names>LR</given-names></name>, <name><surname>Cleary</surname><given-names>PA</given-names></name></person-group>
<article-title>Confirmation of the dimensional structure of the SCL-90: a study in construct validation</article-title>. <source>J Clin Psychol</source>
<year>1977</year>;<volume>33</volume>:<fpage>981</fpage>–<lpage>9</lpage>.</mixed-citation></ref><ref id="R59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Budtz-Lilly</surname><given-names>A</given-names></name>, <name><surname>Fink</surname><given-names>P</given-names></name>, <name><surname>Ørnbøl</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>A new questionnaire to identify bodily distress in primary care: the ‘BDS checklist</article-title>’. <source>J Psychosom Res</source>
<year>2015</year>;<volume>78</volume>:<fpage>536</fpage>–<lpage>45</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jpsychores.2015.03.006">doi:10.1016/j.jpsychores.2015.03.006</ext-link><pub-id pub-id-type="pmid">25818346</pub-id></mixed-citation></ref><ref id="R60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>P</given-names></name>, <name><surname>Ørnbøl</surname><given-names>E</given-names></name>, <name><surname>Huyse</surname><given-names>FJ</given-names></name><etal></etal></person-group>
<article-title>A brief diagnostic screening instrument for mental disturbances in general medical wards</article-title>. <source>J Psychosom Res</source>
<year>2004</year>;<volume>57</volume>:<fpage>17</fpage>–<lpage>24</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0022-3999(03)00374-X">doi:10.1016/S0022-3999(03)00374-X</ext-link><pub-id pub-id-type="pmid">15256291</pub-id></mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Derogatis</surname><given-names>LR</given-names></name></person-group>
<comment>SCL-90-R: Vejledning til administration og scoring. Danish Manual</comment>
<year>1994</year>.</mixed-citation></ref><ref id="R62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>KS</given-names></name>, <name><surname>Bech</surname><given-names>P</given-names></name>, <name><surname>Fink</surname><given-names>P</given-names></name></person-group>
<article-title>Measuring mental health by questionnaires in primary care—unidimensionality, responsiveness and compliance</article-title>. <source>Eur Psychiatr Rev</source>
<year>2010</year>;<volume>3</volume>:<fpage>8</fpage>–<lpage>12</lpage>.</mixed-citation></ref><ref id="R63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>P</given-names></name>, <name><surname>Ewald</surname><given-names>H</given-names></name>, <name><surname>Jensen</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization</article-title>. <source>J Psychosom Res</source>
<year>1999</year>;<volume>46</volume>:<fpage>261</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">10193917</pub-id></mixed-citation></ref><ref id="R64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>EH</given-names></name></person-group>
<article-title>Review of the psychometric evidence of the Perceived Stress Scale</article-title>. <source>Asian Nurs Res (Korean Soc Nurs Sci)</source>
<year>2012</year>;<volume>6</volume>:<fpage>121</fpage>–<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.anr.2012.08.004">doi:10.1016/j.anr.2012.08.004</ext-link><pub-id pub-id-type="pmid">25031113</pub-id></mixed-citation></ref><ref id="R65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurst</surname><given-names>H</given-names></name>, <name><surname>Bolton</surname><given-names>J</given-names></name></person-group>
<article-title>Assessing the clinical significance of change scores recorded on subjective outcome measures</article-title>. <source>J Manipulative Physiol Ther</source>
<year>2004</year>;<volume>27</volume>:<fpage>26</fpage>–<lpage>35</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jmpt.2003.11.003">doi:10.1016/j.jmpt.2003.11.003</ext-link><pub-id pub-id-type="pmid">14739871</pub-id></mixed-citation></ref><ref id="R66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broadbent</surname><given-names>E</given-names></name>, <name><surname>Petrie</surname><given-names>KJ</given-names></name>, <name><surname>Main</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>The brief illness perception questionnaire</article-title>. <source>J Psychosom Res</source>
<year>2006</year>;<volume>60</volume>:<fpage>631</fpage>–<lpage>7</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jpsychores.2005.10.020">doi:10.1016/j.jpsychores.2005.10.020</ext-link><pub-id pub-id-type="pmid">16731240</pub-id></mixed-citation></ref><ref id="R67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spence</surname><given-names>M</given-names></name>, <name><surname>Moss-Morris</surname><given-names>R</given-names></name>, <name><surname>Chalder</surname><given-names>T</given-names></name></person-group>
<article-title>The Behavioural Responses to Illness Questionnaire (BRIQ): a new predictive measure of medically unexplained symptoms following acute infection</article-title>. <source>Psychol Med</source>
<year>2005</year>;<volume>35</volume>:<fpage>583</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">15856728</pub-id></mixed-citation></ref><ref id="R68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boterhoven de Haan</surname><given-names>KL</given-names></name>, <name><surname>Hafekost</surname><given-names>J</given-names></name>, <name><surname>Lawrence</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Reliability and validity of a short version of the general functioning subscale of the McMaster Family Assessment Device</article-title>. <source>Fam Process</source>
<year>2015</year>;<volume>54</volume>:<fpage>116</fpage>–<lpage>23</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/famp.12113">doi:10.1111/famp.12113</ext-link><pub-id pub-id-type="pmid">25385473</pub-id></mixed-citation></ref><ref id="R69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraley</surname><given-names>RC</given-names></name>, <name><surname>Heffernan</surname><given-names>ME</given-names></name>, <name><surname>Vicary</surname><given-names>AM</given-names></name><etal></etal></person-group>
<article-title>The Experiences in Close Relationships-Relationship Structures Questionnaire: a method for assessing attachment orientations across relationships</article-title>. <source>Psychol Assess</source>
<year>2011</year>;<volume>23</volume>:<fpage>615</fpage>–<lpage>25</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1037/a0022898">doi:10.1037/a0022898</ext-link><pub-id pub-id-type="pmid">21443364</pub-id></mixed-citation></ref><ref id="R70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shevlin</surname><given-names>M</given-names></name>, <name><surname>Elklit</surname><given-names>A</given-names></name></person-group>
<article-title>A latent class analysis of adolescent adverse life events based on a Danish national youth probability sample</article-title>. <source>Nord J Psychiatry</source>
<year>2008</year>;<volume>62</volume>:<fpage>218</fpage>–<lpage>24</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/08039480801983992">doi:10.1080/08039480801983992</ext-link><pub-id pub-id-type="pmid">18609032</pub-id></mixed-citation></ref><ref id="R71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vistisen</surname><given-names>ST</given-names></name>, <name><surname>Hansen</surname><given-names>TK</given-names></name>, <name><surname>Jensen</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Heart rate variability in neurorehabilitation patients with severe acquired brain injury</article-title>. <source>Brain Inj</source>
<year>2014</year>;<volume>28</volume>:<fpage>196</fpage>–<lpage>202</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3109/02699052.2013.860477">doi:10.3109/02699052.2013.860477</ext-link><pub-id pub-id-type="pmid">24295072</pub-id></mixed-citation></ref><ref id="R72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanzini</surname><given-names>M</given-names></name>, <name><surname>Petroski</surname><given-names>EL</given-names></name>, <name><surname>Ohara</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>Calibration of ActiGraph GT3X, Actical and RT3 accelerometers in adolescents</article-title>. <source>Eur J Sport Sci</source>
<year>2014</year>;<volume>14</volume>:<fpage>91</fpage>–<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/17461391.2012.732614">doi:10.1080/17461391.2012.732614</ext-link><pub-id pub-id-type="pmid">24533499</pub-id></mixed-citation></ref><ref id="R73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>A</given-names></name>, <name><surname>Oernboel</surname><given-names>E</given-names></name>, <name><surname>Licht</surname><given-names>RW</given-names></name><etal></etal></person-group>
<article-title>Outcome measurement in functional somatic syndromes: SF-36 summary scores and some scales were not valid</article-title>. <source>J Clin Epidemiol</source>
<year>2012</year>;<volume>65</volume>:<fpage>30</fpage>–<lpage>41</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jclinepi.2011.03.012">doi:10.1016/j.jclinepi.2011.03.012</ext-link><pub-id pub-id-type="pmid">21764558</pub-id></mixed-citation></ref><ref id="R74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mease</surname><given-names>P</given-names></name>, <name><surname>Arnold</surname><given-names>LM</given-names></name>, <name><surname>Bennett</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Fibromyalgia syndrome</article-title>. <source>J Rheumatol</source>
<year>2007</year>;<volume>34</volume>:<fpage>1415</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">17552068</pub-id></mixed-citation></ref><ref id="R75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S</given-names></name>, <name><surname>Kamarck</surname><given-names>T</given-names></name>, <name><surname>Mermelstein</surname><given-names>R</given-names></name></person-group>
<article-title>A global measure of perceived stress</article-title>. <source>J Health Soc Behav</source>
<year>1983</year>;<volume>24</volume>:<fpage>385</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">6668417</pub-id></mixed-citation></ref><ref id="R76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>SS</given-names></name>, <name><surname>Frostholm</surname><given-names>L</given-names></name>, <name><surname>Ørnbøl</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Changes in illness perceptions mediated the effect of cognitive behavioural therapy in severe functional somatic syndromes</article-title>. <source>J Psychosom Res</source>
<year>2015</year>;<volume>78</volume>:<fpage>363</fpage>–<lpage>70</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jpsychores.2014.12.005">doi:10.1016/j.jpsychores.2014.12.005</ext-link><pub-id pub-id-type="pmid">25541119</pub-id></mixed-citation></ref><ref id="R77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>NB</given-names></name>, <name><surname>Baldwin</surname><given-names>LM</given-names></name>, <name><surname>Bishop</surname><given-names>DS</given-names></name></person-group>
<article-title>The McMaster Family Assessment Device</article-title>. <source>J Marital Fam Ther</source>
<year>1983</year>;<volume>9</volume>:<fpage>171</fpage>–<lpage>80</lpage>.</mixed-citation></ref><ref id="R78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devilly</surname><given-names>GJ</given-names></name>, <name><surname>Borkovec</surname><given-names>TD</given-names></name></person-group>
<article-title>Psychometric properties of the credibility/expectancy questionnaire</article-title>. <source>J Behav Ther Exp Psychiatry</source>
<year>2000</year>;<volume>31</volume>:<fpage>73</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">11132119</pub-id></mixed-citation></ref><ref id="R79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tak</surname><given-names>LM</given-names></name>, <name><surname>Riese</surname><given-names>H</given-names></name>, <name><surname>de Bock</surname><given-names>GH</given-names></name><etal></etal></person-group>
<article-title>As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders</article-title>. <source>Biol Psychol</source>
<year>2009</year>;<volume>82</volume>:<fpage>101</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">19463887</pub-id></mixed-citation></ref><ref id="R80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>E</given-names></name>, <name><surname>Koren</surname><given-names>G</given-names></name>, <name><surname>Rieder</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions</article-title>. <source>Psychoneuroendocrinology</source>
<year>2012</year>;<volume>37</volume>:<fpage>589</fpage>–<lpage>601</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.psyneuen.2011.09.009">doi:10.1016/j.psyneuen.2011.09.009</ext-link><pub-id pub-id-type="pmid">21974976</pub-id></mixed-citation></ref><ref id="R81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeckel</surname><given-names>CM</given-names></name>, <name><surname>Lopes</surname><given-names>RP</given-names></name>, <name><surname>Berleze</surname><given-names>MC</given-names></name><etal></etal></person-group>
<article-title>Neuroendocrine and immunological correlates of chronic stress in ‘strictly healthy’ populations</article-title>. <source>Neuroimmunomodulation</source>
<year>2010</year>;<volume>17</volume>:<fpage>9</fpage>–<lpage>18</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000243080">doi:10.1159/000243080</ext-link><pub-id pub-id-type="pmid">19816052</pub-id></mixed-citation></ref><ref id="R82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Euteneuer</surname><given-names>F</given-names></name>, <name><surname>Schwarz</surname><given-names>MJ</given-names></name>, <name><surname>Hennings</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Psychobiological aspects of somatization syndromes: contributions of inflammatory cytokines and neopterin</article-title>. <source>Psychiatry Res</source>
<year>2012</year>;<volume>195</volume>:<fpage>60</fpage>–<lpage>5</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.psychres.2011.07.032">doi:10.1016/j.psychres.2011.07.032</ext-link><pub-id pub-id-type="pmid">21864915</pub-id></mixed-citation></ref><ref id="R83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name>, <name><surname>Twisk</surname><given-names>FN</given-names></name>, <name><surname>Kubera</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-alpha, PMN-elastase, lysozyme and neopterin</article-title>. <source>J Affect Disord</source>
<year>2012</year>;<volume>136</volume>:<fpage>933</fpage>–<lpage>9</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jad.2011.09.004">doi:10.1016/j.jad.2011.09.004</ext-link><pub-id pub-id-type="pmid">21975140</pub-id></mixed-citation></ref><ref id="R84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name>, <name><surname>Twisk</surname><given-names>FN</given-names></name>, <name><surname>Ringel</surname><given-names>K</given-names></name></person-group>
<article-title>Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression</article-title>. <source>Psychother Psychosom</source>
<year>2012</year>;<volume>81</volume>:<fpage>286</fpage>–<lpage>95</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000336803">doi:10.1159/000336803</ext-link><pub-id pub-id-type="pmid">22832503</pub-id></mixed-citation></ref><ref id="R85"><label>85</label><mixed-citation publication-type="other"><collab>DanFunD Project [Internet]</collab>. <comment>2016. <ext-link ext-link-type="uri" xlink:href="http://www.danfund.org">http://www.danfund.org</ext-link></comment></mixed-citation></ref><ref id="R86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalder</surname><given-names>T</given-names></name>, <name><surname>Goldsmith</surname><given-names>KA</given-names></name>, <name><surname>White</surname><given-names>PD</given-names></name><etal></etal></person-group>
<article-title>Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial</article-title>. <source>Lancet Psychiatry</source>
<year>2015</year>;<volume>2</volume>:<fpage>141</fpage>–<lpage>52</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S2215-0366(14)00069-8">doi:10.1016/S2215-0366(14)00069-8</ext-link><pub-id pub-id-type="pmid">26359750</pub-id></mixed-citation></ref><ref id="R87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>KF</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name></person-group>, <collab>CONSORT Group</collab>. <article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials</article-title>. <source>Ann Intern Med</source>
<year>2010</year>;<volume>152</volume>:<fpage>726</fpage>–<lpage>32</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00232">doi:10.7326/0003-4819-152-11-201006010-00232</ext-link><pub-id pub-id-type="pmid">20335313</pub-id></mixed-citation></ref><ref id="R88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rief</surname><given-names>W</given-names></name>, <name><surname>Broadbent</surname><given-names>E</given-names></name></person-group>
<article-title>Explaining medically unexplained symptoms—models and mechanisms</article-title>. <source>Clin Psychol Rev</source>
<year>2007</year>;<volume>27</volume>:<fpage>821</fpage>–<lpage>41</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cpr.2007.07.005">doi:10.1016/j.cpr.2007.07.005</ext-link><pub-id pub-id-type="pmid">17716793</pub-id></mixed-citation></ref><ref id="R89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ravenzwaaij</surname><given-names>J</given-names></name>, <name><surname>Olde Hartman</surname><given-names>T</given-names></name>, <name><surname>van Ravesteijn</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Explanatory models of medically unexplained symptoms: a qualitative analysis of the literature</article-title>. <source>Ment Health Fam Med</source>
<year>2010</year>;<volume>7</volume>:<fpage>223</fpage>–<lpage>31</lpage>.<pub-id pub-id-type="pmid">22477946</pub-id></mixed-citation></ref></ref-list></back></article>